EurekaMag
+ Translate
+ Most Popular
Advantages and disadvantages of bordeaux mixture and of lime-sulphur used on apples in the growing season
Observations on the Umaria marine bed
10 years of hearing conservation in the Royal Air Force
Chocolate crumb - dairy ingredient for milk chocolate
Effect of daily gelatin ingestion on human scalp hair
Comparison of rice bran and maize bran as feeds for growing and fattening pigs
The composition of pampas-grass (Cortaderia argentea.)
The Accraian Series:
The mechanism of the Liebermann-Burchard reaction of sterols and triterpenes and their esters
Cerebrovascular Doppler ultrasound studies (cv-Doppler)
Toria: PT-303 - first national variety
Hair growth promoting activity of tridax procumbens
Productivity of Pekin x Khaki Campbell ducks
A stable cytosolic expression of VH antibody fragment directed against PVY NIa protein in transgenic potato plant confers partial protection against the virus
Solar treatment of wheat loose smut
Swimmers itch in the Lake of Garda
Bactofugation and the Bactotherm process
The effects of prefrontal lobotomy on aggressive behavior in dogs
Visual rating scales for screening whorl-stage corn for resistance to fall armyworm
Breakdown of seamounts at the trench axis, viewed from gravity anomaly
Kooken; pennsylvania's toughest cave
Recovery of new dinosaur and other fossils from the Early Cretaceous Arundel Clay facies (Potomac Group) of central Maryland, U.S.A
Zubor horny (Bison bonasus) v prirodnych podmienkach Slovensku
The extended Widal test in the diagnosis of fevers due to Salmonella infection
Hair of the american mastodon indicates an adaptation to a semi aquatic habitat

List of PDF Full Texts available from EurekaMag Chapter 46971

Chapter 46971 contains a list of PDF Full Texts available from EurekaMag.




Pharmacy services in hospice organizations
, Hospital Formulary 17(10): 1333-6 1338 (1982)

Pharmacy services to long term facilities--diversification strategy? A survey of Illinois hospital pharmacists
, Hospital Pharmacy 24(11): 917 (1989)

Pharmacy services. High street lows
, Health Service Journal 111(5769): 27 (2001)

Pharmacy services: achieving equitable reimbursement
, Medical Marketing and Media 15(10): 38 40 42 Passim (1980)

Pharmacy services: next summit for chains. Consultant pharmacists brace for stiffer competition
, Contemporary Longterm Care 15(8): 28-30 39 72 (1992)

Pharmacy settles privacy claim about worker's prescriptions for HIV
, Aids Policy and Law 9(24): 2-3 (1995)

Pharmacy sources of drug information
, Drug Information Journal 13(1): 15-20 (1979)

Pharmacy staff interventions in a medical center hematology-oncology service
, Journal of the American Pharmaceutical Association 38(4): 451-456 (1998)

Pharmacy staff training and development: upside-down thinking in a changing profession
, Topics in Hospital Pharmacy Management 12(1): 1-8 (1992)

Pharmacy status v standards: an updated survey
, Current Concepts in Hospital Pharmacy Management 6(1): 9-11 (1984)

Pharmacy strategies for antibiotic review
, Topics in Hospital Pharmacy Management 1(3): 53-64 (1981)

Pharmacy student and faculty perceptions on pharmacy career opportunities. Report of the Professional Affairs Committee
, American Journal of Pharmaceutical Education 50(4): 444-449 (1986)

Pharmacy student expectations for professional practice
, Managed Care Interface 11(8): 50-55 (1998)

Pharmacy student knowledge, attitudes, and beliefs about selling syringes to injection drug users
, Journal of the American Pharmaceutical Association 42(6 Suppl 2): S34-S39 (2002)

Pharmacy student training in United States hospices
, American Journal of Hospice and Palliative Care 18(3): 181-186 (2001)

Pharmacy student's recommendations appreciated by rural community
, Commitment 3(2): 16-17 (1978)

Pharmacy students internship at a nursing home: "reach and touch someone"
, Nursing homes and senior citizen care 36(1): 37-40 (1987)

Pharmacy students of the Universities of Strasbourg and Clermont-Ferrand victime of nazi barbarity, in 1943
, Revue d'Histoire de la Pharmacie 47(323): 309-316 (1999)

Pharmacy students' experience with identifying and solving drug-related problems during clinical clerkship
, American Journal of Hospital Pharmacy 50(2): 294-296 (1993)

Pharmacy study to focus on outcomes
, Modern Healthcare 22(45): 18 (1992)

Pharmacy surveys
, Msda Journal: Journal of the Maryland State Dental Association 39(2): 93-94 (1996)

Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001-2002)
, Journal of the American Pharmaceutical Association 42(6 Suppl 2): S83-S87 (2002)

Pharmacy systems review
, Healthcare Informatics: the Business Magazine for Information and Communication Systems 7(5): 46 48-46 50 (1990)

Pharmacy team recommendations
, American Journal of Managed Care 6(14 Suppl): S774-S777 (2000)

Pharmacy technician competency. A comparative evaluation of formally trained and on-the-job-trained pharmacy technicians in Minnesota. Part I
, Journal of Pharmacy Technology: Jpt: Official Publication of the Association of Pharmacy Technicians 7(3): 100-103 (1991)

Pharmacy technician competency. Part II: Study design, hypotheses, and results
, Journal of Pharmacy Technology: Jpt: Official Publication of the Association of Pharmacy Technicians 7(5): 184-194 (1991)

Pharmacy technician competency. Part III: Statistical analysis of study results
, Journal of Pharmacy Technology: Jpt: Official Publication of the Association of Pharmacy Technicians 7(6): 227-233 (1991)

Pharmacy technician competency. Part IV: Attitudes
, Journal of Pharmacy Technology: Jpt: Official Publication of the Association of Pharmacy Technicians 8(1): 23-26 (1992)

Pharmacy technician helps cancer patients look good
, American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 56(3): 208 (1999)

Pharmacy technician proficiency--factual knowledge, dispensing skills, and attitudes
, Contemporary Pharmacy Practice 1(1): 13-17 (1978)

Pharmacy technician refill checking: safe and practical
, Canadian Journal of Hospital Pharmacy 47(3): 117-9 122-3 (1994)

Pharmacy technician training and education
, Topics in Hospital Pharmacy Management 4(2): 12-18 (1984)

Pharmacy technician unit dose certification program
, Canadian Journal of Hospital Pharmacy 48(5): 290-291 (1995)

Pharmacy technician's role in an ambulatory care infusion clinic
, American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 57(18): 1664-1665 (2000)

Pharmacy technicians and computer technology to support clinical pharmacy services
, American Journal of Hospital Pharmacy 50(5): 929-934 (1993)

Pharmacy technicians and pharmacists in Papua New Guinea
, World Health Forum 17(1): 80-81 (1996)

Pharmacy technicians as members of care teams
, American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 55(17): 1810-1812 (1998)

Pharmacy technicians in managed care
, Managed Care Interface 11(3): 64-65 (1998)

Analytical similarity assessment of rituximab biosimilar CT-P10 to reference medicinal product
, Mabs 10(3): 380-396 (2018)

Pharmacy technicians: varying roles and responsibilities
, Journal of Pharmacy Technology: Jpt: Official Publication of the Association of Pharmacy Technicians 5(1): 23-26 (1989)

Pharmacy technology of the ICU. Today and tomorrow
, Critical Care Clinics 16(4): 641-658 (2000)

Pharmacy temps have pluses, minuses
, Modern Healthcare 23(13): 49 (1993)

Pharmacy through the ages. Aspirin: past, present, and future
, Journal of the American Pharmaceutical Association 42(3): 522 (2002)

Pharmacy through the ages. Hypericum perforatum
, Journal of the American Pharmaceutical Association 42(3): 382 (2002)

Pharmacy through the ages. Taraxacum officinale
, Journal of the American Pharmaceutical Association 41(4): 617 (2001)

Pharmacy tokens
, Nordisk Medicinhistorisk Arsbok 1994: 75-85 (1994)

Pharmacy update. An AIDS challenge
, Provider 20(1): 54 57 (1994)

Pharmacy without walls
, American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 53(4): 418-425 (1996)

Pharmacy workload management at Lutheran Hospital-LaCrosse
, Computers in Healthcare 9(12): 32-33 (1988)

Pharmacy's attempts to extend its roles: a case study in South Africa
, Social Science and Medicine 47(2): 153-164 (1998)

Pharmacy's changing role in dispensing and administration
, American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 57(19): 1755 (2000)

Pharmacy's contribution to public health in the 20th century
, Journal of the American Pharmaceutical Association 39(6): 744-745 (1999)

Pharmacy's database--in its 30th year
, American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 56(17): 1719 (1999)

Pharmacy's framework for drug therapy management
, Managed Care Interface 15(7): 33-34 (2002)

Pharmacy's lifeline to the North
, C.H.A.C. Review 20(1): 19-20 22 (1992)

Pharmacy's private practitioner
, Drug Intelligence and Clinical Pharmacy 9(9): 513 (1975)

Pharmacy's quest for professional direction
, Drug Intelligence and Clinical Pharmacy 9(1): 45-46 (1975)

Pharmacy's response to competing demands
, American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 57(17): 1577 (2000)

Pharmacy's role in quality assurance of medication administration
, Topics in Hospital Pharmacy Management 7(4): 45-54 (1988)

Pharmacy's role in the evolving health care system: quality, cost but mostly access
, Hospital Pharmacy 23(12): 1071-4 1077-9 (1988)

Pharmacy's role within a multidisciplinary, patient-focused model for health care
, Topics in Hospital Pharmacy Management 10(4): 67-74 (1991)

Pharmacy's social movement at the turn of the century: introduction to pharmaceutical care symposium
, Pharmacy in History 43(2-3): 66-74 (2001)

Pharmacy's transition to a proactive practice mode
, American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 52(24): 2821-2824 (1995)

Pharmacy's vision of its future in managed care
, American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 55(14): 1471 (1998)

Pharmacy, Medicines and Poisons Act (No. 15 of 1988), 18 May 1988
, Annual Review of Population Law 15: 17 301-5 (1988)

Pharmacy, apothecaries and the spirit of Thorbecke. The shaping of the pharmaceutical discipline at the end of the nineteehtn century
, Gewina 19(4): 280-295 (1996)

Pharmacy, pharmacopoeias, medicines and traditional remedies in Congo
, Bulletin - Cercle Benelux d'Histoire de la Pharmacie 1996(91): 8-21 (1996)

Pharmacy--health centers: assessing the public's needs
, Health and Social Service Journal 90(4685): 384-385 (1980)

Pharmacy--quo vadis?
, Health Matrix 1(2): 63-65 (1983)

Pharmacy--today and tomorrow
, Contemporary Pharmacy Practice 1(1): V (1978)

Pharmacy-based automated medication records: methods, application, and a survey of use
, Topics in Hospital Pharmacy Management 14(3): 58-72 (1994)

Pharmacy-based care for perimenopausal and postmenopausal women
, Journal of the American Pharmaceutical Association 42(5): 700 (2002)

Pharmacy-based consulting on dietary supplements
, Journal of the American Pharmaceutical Association 41(2): 181-191 (2001)

Pharmacy-based diabetes management: a practical approach
, Journal of the American Pharmaceutical Association Ns37(4): 443-55; Quiz 455-7 (1997)

Pharmacy-based drug information services in Hong Kong hospitals
, American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 55(11): 1164-1166 (1998)

Pharmacy-based immunizations--an idea whose time has come
, Journal of the American Pharmaceutical Association 41(1): 13-14 (2001)

Pharmacy-based investigational drug services: a national survey
, Topics in Hospital Pharmacy Management 13(1): 1-15 (1993)

Pharmacy-based laboratory testing: adding another dimension to pharmaceutical care
, Journal of the American Pharmaceutical Association 38(5): 538-540 (1998)

Pharmacy-based skin-testing program in a community hospital
, American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 53(17): 2062-2067 (1996)

Pharmacy-based therapeutic drug monitoring
, American Pharmacy Ns33(7): 57-64; quiz 65-6 (1993)

Pharmacy-buzzword bingo
, American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 56(23): 2464 (1999)

Pharmacy-clinic medication of the month. Naratriptan (naramig)
, Revue Medicale de Liege 54(3): 189-191 (1999)

Pharmacy-clinics medication of the month. Orlistate (xenical)
, Revue Medicale de Liege 54(3): 192-196 (1999)

Pharmacy-controlled drug administration: a proposed solution to the nursing shortage
, Current Concepts in Hospital Pharmacy Management 5(3): 6-10 (1983)

Pharmacy-coordinated, multidisciplinary adverse drug reaction program
, Topics in Hospital Pharmacy Management 12(2): 49-59 (1992)

Pharmacy-initiated intravenous infusion guidelines
, Hospital Pharmacy 17(2): 60 (1982)

Pharmacy-laboratory interactions: a unique method to control antibiotic costs
, Hospital Pharmacy 24(1): 26-9 32 (1989)

Pharmacy-managed extended-interval aminoglycoside program in a community hospital
, American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 55(4): 397-398 (1998)

Pharmacy-managed program for home treatment of deep vein thrombosis with enoxaparin
, American Journal of Health-System Pharmacy: Ajhp: Official Journal of the American Society of Health-System Pharmacists 54(17): 1968-1972 (1997)

Pharmacy-managed, weight-based heparin protocol
, American Journal of Hospital Pharmacy 50(2): 279-284 (1993)

Pharmacy-nursing cooperation in a unit dose drug delivery system
, Hospital Materiel Management Quarterly 8(2): 77-80 (1986)

Pharmacy-nursing facsimile systems: set-up considerations and operational issues
, Hospital Pharmacy 27(2): 111-5 132 (1992)

Pharmacy-nursing report form used to monitor and adjust schedules of large volume parenteral solutions
, Hospital Pharmacy 22(6): 574-577 (1987)

Pharmacy-related accreditation activities consolidated
, Joint Commission perspectives. Joint Commission on Accreditation of Healthcare Organizations 20(6): 15 (2000)

Pharmacy-related standards in the 1994 AMH; drug samples; and adverse drug reaction requirements
, Hospital Pharmacy 29(1): 73-75 (1994)

Pharmacy. A bar to bar codes
, Hospitals and Health Networks 76(5): 24 (2002)

Pharmacy. Presenting effective inservice programs
, Contemporary Longterm Care 14(2): 66 86 (1991)

Pharmacy. Shop talk
, Health Service Journal 108(5617): 25 (1998)

Pharmacy. Waste not, want not
, Health Service Journal 110(5719): 31 (2000)

Pharmacy/purchasing cooperation saves time and money
, Hospital Purchasing Management 6(8): 8-9 (1981)

Pharmacy: a comparative study in general practice in 52 countries
, Hospital Formulary 10(7): 333-336 (1975)

Pharmacy: a profession of issues and opportunities
, Hospital Pharmacy 26(11): 939-946 (1991)

Pharmacy: a unique opportunity to participate in education
, Health and Social Service Journal 90(4688): 479-480 (1980)

Pharmacy: critic says we neglect aging problem
, Hospital Administration in Canada 20(3): 18-19 (1978)

Pharmacy: eight signposts to follow after Noel Hall milestone
, Health and Social Service Journal 90(4692): 612-614 (1980)

Pharmacy: financial viability and public needs
, Health and Social Service Journal 90(4686): 420-421 (1980)

Pharmacy: forgotten link in infection control?
, Hospital Infection Control 6(3): 30-32 (1979)

Pharmacy: the Saudi experience
, Military Medicine 158(2): 96-99 (1993)

Pharmacy: training for co-operation
, Health and Social Service Journal 90(4684): 348-349 (1980)

Pharmaokinetics of beta-escin after administration of various Aesculus extract containing formulations
, Die Pharmazie 51(8): 577-581 (1996)

Pharmaphilia and pharmaphobia
, Clinics in Dermatology 19(1): 69-71 (2001)

Pharmcognostial study on the Geranium wilfordii var. glandulosum
, Zhong Yao Cai 21(8): 385-388 (1998)

Pharmcokinetics in healthy volunteers and patients of NAc-SDKP (seraspenide), a negative regulator of hematopoiesis
, Drug Metabolism and Disposition: the Biological Fate of Chemicals 22(6): 843-848 (1994)

Pharmepéna-Psychonautics: Human intranasal, sublingual and oral pharmacology of 5-methoxy-N,N-dimethyl-tryptamine
, Journal of Psychoactive Drugs 33(4): 403-407 (2001)

Pharmocokinetics of ciprofloxacine
, Presse Medicale 27(14): 690-692 (1998)

Pharmocologic inhibitors of the mitogen activated protein kinase cascade have the potential to interact with ionizing radiation exposure to induce cell death in carcinoma cells by multiple mechanisms
, Cancer Biology and Therapy 1(2): 168-176 (2002)

Pharoah ants & methoprene
, Executive Housekeeping Today 4(3): 14-15 (1983)

Pharyngeal Wegener's disease: a case report
, Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 118(3): 187-192 (2001)

Pharyngeal abscess in a child
, Duodecim; Laaketieteellinen Aikakauskirja 116(3): 313,315 (2000)

Pharyngeal abscess in a small infant presenting as upper airway obstruction and atlanto-axial subluxation
, Anaesthesia 55(9): 927-928 (2000)

Pharyngeal abscess presenting with upper airway obstruction and atlanto-axial subluxation in a small infant
, Anaesthesia 55(5): 469-471 (2000)

Pharyngeal acid reflux events in patients with vocal cord nodules
, Laryngoscope 108(8 Pt 1): 1146-1149 (1998)

Pharyngeal airway changes associated with mandibular advancement
, Journal of Oral and Maxillofacial Surgery: Official Journal of the American Association of Oral and Maxillofacial Surgeons 52(1): 40 (1994)

Pharyngeal airway space changes after counterclockwise rotation of the maxillomandibular complex
, American Journal of Orthodontics and Dentofacial Orthopedics: Official Publication of the American Association of Orthodontists its Constituent Societies and the American Board of Orthodontics 120(2): 154-159 (2001)

Pharyngeal and laryngeal hamartoma: case report
, Acta Otorhinolaryngologica Italica: Organo Ufficiale Della Societa Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale 22(1): 39-41 (2002)

Pharyngeal and nasal swabs in upper airway infections in children. Considerations on results obtained at a Pediatric Unit during 1 year
, Minerva Pediatrica 50(9): 415-416 (1998)

Pharyngeal and upper esophageal sphincter manometry in the evaluation of dysphagia
, Journal of Clinical Gastroenterology 33(5): 355-361 (2001)

Pharyngeal branchial cyst: description of one clinical case
, Acta Otorrinolaringologica Espanola 53(1): 50-53 (2002)

Pharyngeal branchial cyst: magnetic resonance findings
, European Journal of Radiology 29(1): 1-3 (1998)

Pharyngeal chordoma
, Acta Otorrinolaringologica Espanola 48(1): 61-63 (1997)

Pharyngeal clearance and pharyngeal transit time determined by a biomagnetic method in normal humans
, Dysphagia 16(4): 308-312 (2001)

Pharyngeal closure after pharyngolaryngectomy
, Otolaryngologia Polska 54(1): 47-49 (2000)

Pharyngeal coin removal in children
, Journal of Accident and Emergency Medicine 14(3): 175-176 (1997)

Pharyngeal colonization prevalence rates for Streptococcus pyogenes and Streptococcus pneumoniae in a respiratory chemoprophylaxis intervention study using azithromycin
, Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 6(1): 2-8 (2000)

Pharyngeal constriction in elderly dysphagic patients compared with young and elderly nondysphagic controls
, Dysphagia 16(4): 272-278 (2001)

Pharyngeal critical pressure in patients with obstructive sleep apnea syndrome. Clinical implications
, American Journal of Respiratory and Critical Care Medicine 159(1): 149-157 (1999)

Pharyngeal cross-sectional area and pharyngeal compliance in normal Japanese males and females
, Nihon Kyobu Shikkan Gakkai Zasshi 31(11): 1432-1440 (1993)

Pharyngeal cysts of branchial origin, a review of the literature and a clinical case report
, Acta Otorhinolaryngologica Italica: Organo Ufficiale Della Societa Italiana di Otorinolaringologia e Chirurgia Cervico-Facciale 13(2): 169-179 (1993)

Pharyngeal dysphagia and polymyositis
, Gastroenterologie Clinique et Biologique 17(6-7): 502-504 (1993)

Pharyngeal dysphagia caused by isolated myogen dystrophy of musculus cricopharyngeus
, Acta Chirurgica Hungarica 37(1-2): 51-58 (1998)

Pharyngeal dysphagia in postesophagectomy patients: correlation with deglutitive biomechanics
, Annals of Thoracic Surgery 69(4): 989-992 (2000)

Pharyngeal findings of group A streptococcal pharyngitis
, Archives of Pediatrics and Adolescent Medicine 152(9): 927-928 (1998)

Pharyngeal flap and the internal carotid in velocardiofacial syndrome
, Archives of Facial Plastic Surgery 4(2): 73-80 (2002)

Pharyngeal flap for velopharyngeal incompetence in patients with myotonic dystrophy
, Annals of Plastic Surgery 42(5): 549-552 (1999)

Pharyngeal flap revisions: flap elevation from a scarred posterior pharynx
, Plastic and Reconstructive Surgery 93(2): 279-284 (1994)

Pharyngeal flora in patients undergoing head and neck oncologic surgery
, Acta Oto-Rhino-Laryngologica Belgica 53(3): 237-240 (1999)

Pharyngeal foreign bodies in infants persisting for two months: two case reports
, Nihon Jibiinkoka Gakkai Kaiho 103(1): 24-27 (2000)

Pharyngeal foreign body
, Journal of Emergency Medicine 21(1): 65-66 (2001)

Pharyngeal foreign body in a child persisting for three years
, Emergency Medicine Journal: Emj 19(4): 361-362 (2002)

Pharyngeal lipoma
, Anales Otorrinolaringologicos Ibero-Americanos 21(3): 247-254 (1994)

Pharyngeal localizations of branchial cysts
, European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies: Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 255(7): 379-381 (1998)

Pharyngeal muscles and sleep obstructive apnea syndrome
, Revue des Maladies Respiratoires 16(1): 51-56 (1999)

Pharyngeal musculature and obstructive sleep apnea syndromes
, Revue des Maladies Respiratoires 17(Suppl): S15-S20 (2000)

Pharyngeal obstruction caused by tonsil hypertrophy in children
, Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 110(1): 10-17 (1993)

Pharyngeal pH measurements in patients with respiratory symptoms before and during proton pump inhibitor therapy
, American Journal of Surgery 181(5): 466-470 (2001)

Pharyngeal pH monitoring in 222 patients with suspected laryngeal reflux
, Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 5(2): 183-90; Discussion 190-1 (2001)

Pharyngeal patency caused by stimulation of the hypoglossal nerve in anaesthesia-relaxed patients
, Acta Oto-Laryngologica. Supplementum 529: 210-211 (1997)

Pharyngeal perforation and spontaneous extrusion of the cervical graft with its fixation device: a late complication of C2-C3 fusion via anterior approach
, Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 8(5): 464-468 (2001)

Pharyngeal pouch carcinoma
, Ear Nose and Throat Journal 72(2): 149-150 (1993)

Pharyngeal pouch endoscopic stapling--are post-operative barium swallow radiographs of any value?
, Journal of Laryngology and Otology 113(3): 233-236 (1999)

Pharyngeal pouch following anterior cervical fusion
, Journal of Laryngology and Otology 112(11): 1085-1086 (1998)

Pharyngeal pouch surgery: a five year review
, Revue de Laryngologie - Otologie - Rhinologie 121(1): 37-40 (2000)

Pharyngeal pressure measurements in topodiagnosis of obstructive sleep apnea
, Hno 45(11): 898-904 (1997)

Pharyngeal reconstruction after salvage pharyngolaryngectomy in recurrent tumors
, Hno 50(12): 1068-1074 (2002)

Pharyngeal reflux after gastric pull-up esophagectomy with neck and chest anastomoses
, Journal of Thoracic and Cardiovascular Surgery 118(6): 1078-1083 (1999)

Pharyngeal scars stenosis in children
, Vestnik Otorinolaringologii 1997(2): 21-23 (1997)

Pharyngeal solid-state manometry catheter movement during swallowing in dysphagic and nondysphagic participants
, Academic Radiology 1(4): 339-344 (1994)

Pharyngeal stromal tumor
, Gastrointestinal Endoscopy 51(3): 328 (2000)

Pharyngeal swallowing disorders: selection for and outcome after myotomy
, Annals of Surgery 228(4): 598-608 (1998)

Pharyngeal swallowing. The major factor in clearance of esophageal reflux episodes
, Annals of Surgery 218(3): 364-9; Discussion 369-70 (1993)

Pharyngeal teratoma
, Anaesthesia 48(9): 792-794 (1993)

Pharyngeal trauma in children--accidental and otherwise
, Journal of Laryngology and Otology 109(12): 1168-1175 (1995)

Pharyngeal tuberculosis as a differential diagnosis to carcinoma
, Hno 41(1): 37-40 (1993)

Pharyngeal tuberculosis: a clinical case
, Acta Otorrinolaringologica Espanola 49(7): 587-590 (1998)

Pharyngeal tuberculosis: an analytical study and report of 10 cases
, Revue de Laryngologie - Otologie - Rhinologie 119(3): 203-207 (1998)

Pharyngeal wall perforation--an unusual complication of blind intubation with a gum elastic bougie
, Anaesthesia 54(4): 404-405 (1999)

Pharyngitis and exanthema caused by Arcanobacterium haemolyticum
, Acta Dermato-Venereologica 81(2): 143-144 (2001)

Pharyngitis followed by hypoxia and sepsis: Lemierre syndrome
, American Journal of Emergency Medicine 19(4): 320-322 (2001)

Pharyngitis in children
, Postgraduate Medicine 93(3): 141-145 (1993)

Pharyngitis in children. Determining the etiology is essential
, Advance for Nurse Practitioners 7(7): 47-50 (1999)

Pharyngitis produced by Arcanobacterium haemolyticum
, Bacteriologia Virusologia Parazitologia Epidemiologia 41(3-4): 135-140 (1996)

Pharyngitis. Etiology, diagnosis, clinical course, treatment
, La Revue du Praticien 43(18): 2417-2420 (1993)

Pharyngitis. Etiology, diagnosis, course, treatment
, La Revue du Praticien 47(4): 451-456 (1997)

Pharyngitis: how can so simple a disease be so complex?
, Academic Emergency Medicine: Official Journal of the Society for Academic Emergency Medicine 5(6): 559-561 (1998)

Pharyngo-cutaneous fistula after total laryngectomy
, Nihon Jibiinkoka Gakkai Kaiho 100(2): 213-219 (1997)

Pharyngo-enteral anastomosis for esophageal reconstruction in diffuse corrosive esophageal stricture
, Annals of Thoracic Surgery 72(4): 1141-1143 (2001)

Pharyngo-esophageal reconstruction
, Acta Chirurgica Iugoslavica 46(1-2): 57-65 (1999)

Pharyngo-esophagoplasty by right coloplasty for the treatment of post-caustic pharyngo-laryngeal-esophageal burns: a report of 13 cases
, Annales d'Oto-Laryngologie et de Chirurgie Cervico Faciale: Bulletin de la Societe d'Oto-Laryngologie des Hopitaux de Paris 117(3): 147-154 (2000)

Pharyngo-gastric anastomosis
, Zhonghua Er Bi Yan Hou Ke Za Zhi 28(1): 47-8 60 (1993)

Pharyngo-gastric anastomosis following pharyngo-laryngo-esophagectomy for cancer
, Harefuah 125(11): 404-7 447 (1993)

Pharyngo-oesophageal dysphagia: surgery based on clinical and manometric data
, European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 10(5): 365-371 (1996)

Pharyngo-tonsillitis and necrosing submaxillary adenitis caused by Streptococcus pyogenes associated with toxic shock syndrome in children from Mexico City
, Boletin Medico del Hospital Infantil de Mexico 50(8): 564-569 (1993)

Pharyngocele
, Acta Otorrinolaringologica Espanola 45(3): 215-217 (1994)

Pharyngocutaneous fistula after laryngectomy--incidence, predisposing factors and outcome
, Singapore Medical Journal 40(3): 130-132 (1999)

Pharyngocutaneous fistula as a complication of total laryngectomy: review of the literature and analysis of case records
, Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 123(5): 587-592 (2000)

Pharyngoesophageal (Zenker's) diverticulum mimicking thyroid nodule on ultrasonography: report of two cases
, Journal of Ultrasound in Medicine: Official Journal of the American Institute of Ultrasound in Medicine 13(4): 319-322 (1994)

Pharyngoesophageal (Zenker's) diverticulum: case report
, East African Medical Journal 79(1): 54-55 (2002)

Pharyngoesophageal dysfunction: report of case and review of literature
, Revista do Hospital das Clinicas 51(3): 103-105 (1996)

Pharyngoesophageal foreign bodies
, Acta Otorrinolaringologica Espanola 51(4): 335-339 (2000)

Pharyngoesophageal pressure monitoring in sleep apnea syndrome
, Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 125(4): 324-331 (2001)

Pharyngoesophageal reconstruction using the tubed free radial forearm flap
, Clinics in Plastic Surgery 21(1): 137-147 (1994)

Pharyngogenesis
, Journal of the Dental Association of South Africa 51(12): 777-782 (1996)

Pharyngoglottal closure reflex: characterization in healthy young, elderly and dysphagic patients with predeglutitive aspiration
, Gerontology 49(1): 12-20 (2003)

Pharyngolaryngeal morbidity with the intubating laryngeal mask airway
, Anaesthesia 53(12): 1231 (1998)

Pharyngolaryngeal xanthomatosis: a case report
, Anales Otorrinolaringologicos Ibero-Americanos 23(4): 397-400 (1996)

Pharyngolaryngectomy with total esophagectomy following concomitant chemoradiotherapy for advanced and/or salvage cases of hypopharyngeal carcinomas
, European Archives of Oto-Rhino-Laryngology: Official Journal of the European Federation of Oto-Rhino-Laryngological Societies: Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 254(6): 304-305 (1997)

Pharyngolaryngoscopic findings in patients with obstructive sleep apnea syndrome and primary snoring
, Hno 48(12): 917-921 (2000)

Pharyngoplasty and the risk of variant CJD transmission
, British Journal of Plastic Surgery 54(6): 552 (2001)

Pharyngoplasty in patients with cleft lip and palate after maxillary advancement
, Journal of Craniofacial Surgery 9(4): 330-5; discussion 336-7 (1998)

Pharyngoscopic views
, Anesthesia and Analgesia 87(3): 748 (1998)

Pharyngotonsillitis in the adult
, Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 11(2): 105-109 (1998)

Phase 1 and 2 trial of bexarotene gel for skin-directed treatment of patients with cutaneous T-cell lymphoma
, Archives of Dermatology 138(3): 325-332 (2002)

Phase 1 clinical study of 123I-FP-CIT, a new radioligand for evaluating dopamine transporter by SPECT (II): Tracer kinetics in the brain
, Kaku Igaku. Japanese Journal of Nuclear Medicine 36(9): 1013-1022 (1999)

Phase 1 clinical trials
, Journal of Cutaneous Medicine and Surgery 2(4): 236-241 (1998)

Phase 1 of a comprehensive course review process: program innovation
, Journal of Dental Education 66(3): 405-413 (2002)

Phase 1 research program overview
, Acta Astronautica 48(5-12): 845-851 (2001)

Phase 1 studies: the development of new dressing technology
, British Journal of Nursing 8(17): 1157-1160 (1999)

Phase 1 study of combination therapy with L-697,661 and zidovudine. The ACTG 184 Protocol Team
, Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 12(4): 363-370 (1996)

Phase 1 study to identify tumour hypoxia in patients with head and neck cancer using technetium-99m BRU 59-21
, European Journal of Nuclear Medicine and Molecular Imaging 29(9): 1206-1211 (2002)

Phase 1 trial of a single dose of recombinant human interleukin-12 in human immunodeficiency virus-infected patients with 100-500 CD4 cells/microL
, Journal of Infectious Diseases 182(4): 1070-1076 (2000)

Phase 1 trial of ifosfamide and adriamycin in metastatic breast cancer
, Jpma. Journal of the Pakistan Medical Association 51(11): 400-405 (2001)

Phase 1 trial of recombinant human interleukin-1 beta (rhIL-1 beta), carboplatin, and etoposide in patients with solid cancers: Southwest Oncology, Group Study 8940
, Cancer Investigation 15(5): 403-410 (1997)

Phase 1, randomized, double-blind trial of 7-allyl-8-oxoguanosine (loxoribine) in advanced cancer
, Cytokines Cellular and Molecular Therapy 6(4): 171-176 (2000)

Phase 1B study of subcutaneously administered interleukin 2 in combination with 13-cis retinoic acid as maintenance therapy in advanced cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7(5): 1251-1257 (2001)

Phase 1B ventricular arrhythmia in the dog: localized reentry within the mid-myocardium
, Journal of Interventional Cardiac Electrophysiology: An International Journal of Arrhythmias and Pacing 2(2): 145-161 (1998)

Phase 2 and 3 clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early-stage cutaneous T-cell lymphoma
, Archives of Dermatology 137(5): 581-593 (2001)

Phase 2 clinical study of 123I-IBF, a dopamine D2 receptor imaging agent, to evaluate clinical efficacy and safety in Parkinson's disease and Parkinson syndromes
, Kaku Igaku. Japanese Journal of Nuclear Medicine 36(8): 845-864 (1999)

Phase 2 clinical study of 123I-iomazenil in various cerebral diseases: part 1--examination of injection dose and clinical indications
, Kaku Igaku. Japanese Journal of Nuclear Medicine 33(2): 179-190 (1996)

Phase 2 clinical study of 123I-iomazenil in various cerebral diseases: part 2--clinical evaluation of central-type benzodiazepine receptor imaging with 123I-iomazenil SPECT
, Kaku Igaku. Japanese Journal of Nuclear Medicine 33(2): 191-205 (1996)

Phase 2 trial of WR6026, an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi
, American Journal of Tropical Medicine and Hygiene 65(6): 685-689 (2001)

Phase 3 clinical study of 99mTc-MAG3 injectable, a dynamic renal imaging agent--comparison with 123I-OIH and 99mTc-DTPA
, Kaku Igaku. Japanese Journal of Nuclear Medicine 31(2): 183-198 (1994)

Phase 3 multicenter clinical study of 111In-DTPA-D-octreotide (MP-1727) in patients with gastrointestinal hormone producing tumors
, Kaku Igaku. Japanese Journal of Nuclear Medicine 32(11): 1269-1280 (1995)

Phase 3, a spring-board in the life of the convalescent cardiac patient
, Revue de l'Infirmiere 2002(84): 44-45 (2002)

Phase 4 or phase 5 in patients with severe preeclampsia?
, American Journal of Obstetrics and Gynecology 168(6 Pt 1): 1893-1895 (1993)

Phase Behavior and Aggregate Structure in Aqueous Mixtures of Sodium Cholate and Glycerol Monooleate
, Journal of Colloid and Interface Science 211(2): 326-335 (1999)

Phase Behavior and Phase Structure of Protein-Surfactant-Water Systems
, Journal of Colloid and Interface Science 218(2): 397-403 (1999)

Phase Behavior and Salt Partitioning in Two- and Three-Phase Anionic Surfactant Microemulsion Systems: Part I, Phase Behavior as a Function of Temperature
, Journal of Colloid and Interface Science 215(2): 201-215 (1999)

Phase Behavior and Salt Partitioning in Two- and Three-Phase Anionic Surfactant Microemulsion Systems: Part II, Partitioning of Salt
, Journal of Colloid and Interface Science 215(2): 216-225 (1999)

Phase Behavior and Structural Changes in Tetraethylorthosilicate-Derived Gels in the Presence of Polyethylene Glycol, Studied by Rheological Techniques and Visual Observations
, Journal of Colloid and Interface Science 204(1): 45-52 (1998)

Phase Behavior of Aqueous Mixtures of Some Polyethylene Glycol Decyl Ethers Revealed by DSC and FT-IR Measurements
, Journal of Colloid and Interface Science 205(2): 305-315 (1998)

Phase Behavior of Binary Mixture of Heptaethylene Glycol Decyl Ether and Water: Formation of Phase Compound in Solid Phase
, Journal of Colloid and Interface Science 191(1): 256-263 (1997)

Phase Behavior of Blends of Polymers and Smectic-A Liquid Crystals
, Macromolecules 31(15): 4879-4890 (1998)

Phase Behavior of Polymers in Supercritical Fluid Solvents
, Chemical Reviews 99(2): 565-602 (1999)

Phase Behavior of a Water/Nonionic Surfactant/Oil Ternary System in the Presence of Polymer Oil
, Journal of Colloid and Interface Science 186(2): 294-299 (1997)

Phase Behavior, Structure, and Physical Properties of the Quaternary System Tetradecyldimethylamine Oxide, HCl, 1-Hexanol, and Water
, Journal of Colloid and Interface Science 221(2): 200-209 (2000)

Phase Conjugation of Weak Continuous-Wave Optical Signals
, Physical Review Letters 77(11): 2202-2205 (1996)

Phase Defects as a Measure of Disorder in Traveling-Wave Convection
, Physical Review Letters 77(13): 2678-2681 (1996)

Phase Diagram and Orientational Order in a Biaxial Lattice Model: A Monte Carlo Study
, Physical Review Letters 75(9): 1803-1806 (1995)

Phase Diagram for a Magnetic Thin Film with Dipolar Interactions and Magnetic Surface Anisotropy
, Physical Review Letters 77(4): 739-742 (1996)

Phase Diagram of Colloidal Solutions
, Physical Review Letters 77(23): 4832-4835 (1996)

Phase Diagram of Correlated Electrons in a Lattice of Berry Phase Molecules
, Physical Review Letters 74(20): 4039-4042 (1995)

Phase Diagram of Isobutyric Acid and Water in Dilute Silica Gel
, Physical Review Letters 77(14): 2969-2972 (1996)

Phase Diffusion in Localized Spatio-Temporal Amplitude Chaos
, Physical Review Letters 77(12): 2451-2454 (1996)

Phase Equilibria and Structure of the 1-Dodecylpyridinium Bromide-Dodecane-Water System
, Journal of Colloid and Interface Science 204(2): 312-319 (1998)

Phase Hamiltonian and depinning electric field in the charge-density wave and the spin-density wave
, Physical Review. B Condensed Matter 42(1): 655-659 (1990)

Phase I Clinical Trial of a Day-1, -3, -5 Every 3 Weeks Phase I Clinical Trial of Day-1, -3, -5 Every 3 Weeks Schedule with Titanocene Dichloride (MKT 5) in Patients with Advanced Cancer. (Phase I Study Group of the AIO of the German Cancer Society)
, Onkologie 23(6): 576-579 (2000)

Phase I Stark II regulations provide some flexibility
, Healthcare Financial Management: Journal of the Healthcare Financial Management Association 55(10): 52-59 (2001)

Phase I Study of RA-700. RA-700 Clinical Study Group
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(1): 67-78 (1993)

Phase I Trial of ISIS 5132, an antisense oligonucleotide inhibitor of c-raf-1, administered by 24-hour weekly infusion to patients with advanced cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7(5): 1214-1220 (2001)

Phase I and II clinical trials of trastuzumab
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(Suppl): S49-S55 (2001)

Phase I and II studies of toremifene
, Oncology 11(5 Suppl 4): 19-22 (1997)

Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(11): 3385-3393 (1999)

Phase I and pharmacokinetic evaluations of UFT plus oral leucovorin
, Oncology 11(9 Suppl 10): 35-39 (1997)

Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(9): 3493-3498 (2000)

Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(5): 1038-1044 (2002)

Phase I and pharmacokinetic study of CI-980 in recurrent pediatric solid tumor cases: a Pediatric Oncology Group study
, Journal of Pediatric Hematology/Oncology 21(6): 494-500 (1999)

Phase I and pharmacokinetic study of D-limonene in patients with advanced cancer. Cancer Research Campaign Phase I/II Clinical Trials Committee
, Cancer ChemoTherapy and Pharmacology 42(2): 111-117 (1998)

Phase I and pharmacokinetic study of DX-8951f (exatecan mesylate), a hexacyclic camptothecin, on a daily-times-five schedule in patients with advanced leukemia
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(7): 2134-2141 (2002)

Phase I and pharmacokinetic study of E7070, a novel chloroindolyl sulfonamide cell-cycle inhibitor, administered as a one-hour infusion every three weeks in patients with advanced cancer
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(16): 3508-3521 (2002)

Phase I and pharmacokinetic study of E7070, a novel sulfonamide, given at a daily times five schedule in patients with solid tumors. A study by the EORTC-early clinical studies group (ECSG)
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(9): 1289-1293 (2001)

Phase I and pharmacokinetic study of GI147211, a water-soluble camptothecin analogue, administered for five consecutive days every three weeks
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(3): 595-604 (1998)

Phase I and pharmacokinetic study of KRN8602 alone and with filgrastim in patients with advanced cancer
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 16(6): 2181-2187 (1998)

Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusion
, Cancer Research 53(5): 1037-1042 (1993)

Phase I and pharmacokinetic study of a micronized formulation of carboxyamidotriazole, a calcium signal transduction inhibitor: toxicity, bioavailability and the effect of food
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(1): 86-94 (2002)

Phase I and pharmacokinetic study of docetaxel in combination with epirubicin and cyclophosphamide in advanced cancer: dose escalation possible with granulocyte colony-stimulating factor, but not with prophylactic antibiotics
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(11): 1810-1818 (2002)

Phase I and pharmacokinetic study of ecteinascidin 743 administered as a 72-hour continuous intravenous infusion in patients with solid malignancies
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7(2): 231-242 (2001)

Phase I and pharmacokinetic study of escalating dose of docetaxel administered with granulocyte colony-stimulating factor support in adult advanced solid tumors
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 9(1): 102-108 (2003)

Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(5): 599-603 (2001)

Phase I and pharmacokinetic study of novel L-nucleoside analog troxacitabine given as a 30-minute infusion every 21 days
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(10): 2567-2574 (2002)

Phase I and pharmacokinetic study of once daily oral administration of S-1 in patients with advanced cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(7): 2116-2122 (2002)

Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2(9): 1461-1467 (1996)

Phase I and pharmacokinetic study of the P-glycoprotein modulator dexniguldipine-HCL
, European Journal of Medical Research 2(2): 55-61 (1997)

Phase I and pharmacokinetic study of the new taxane analog BMS-184476 given weekly in patients with advanced malignancies
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(9): 2788-2797 (2002)

Phase I and pharmacokinetic study of tirapazamine (SR 4233) administered every three weeks
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 3(1): 31-38 (1997)

Phase I and pharmacokinetic study of tomudex combined with 5-fluorouracil plus levofolinic acid in advanced head and neck cancer and colorectal cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(12): 3948-3955 (1999)

Phase I and pharmacokinetic study of two sequences of gemcitabine and docetaxel administered weekly to patients with advanced cancer
, Cancer ChemoTherapy and Pharmacology 48(2): 95-103 (2001)

Phase I and pharmacokinetic study of weekly 5-fluorouracil administered with granulocyte-macrophage colony-stimulating factor and high-dose leucovorin: a potential role for growth factor as mucosal protectant
, Cancer Investigation 17(1): 1-9 (1999)

Phase I and pharmacokinetic study of weekly oral therapy with vinorelbine in patients with advanced breast cancer (ABC)
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(12): 1683-1691 (2001)

Phase I and pharmacokinetic trial of the proapoptotic sulindac analog CP-461 in patients with advanced cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(10): 3100-3104 (2002)

Phase I and pharmacokinetics studies of prochlorperazine 2-h i.v. infusion as a doxorubicin-efflux blocker
, Cancer ChemoTherapy and Pharmacology 34(5): 377-384 (1994)

Phase I and pharmacokinetics study of crotoxin (cytotoxic PLA(2), NSC-624244) in patients with advanced cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(4): 1033-1041 (2002)

Phase I and pharmacokinetics study of topotecan, a new topoisomerase I inhibitor
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 4(8): 673-678 (1993)

Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation in patients with refractory or relapsed acute leukemia
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 10(5): 577-583 (1999)

Phase I and pharmacologic study of a 3-hour infusion of paclitaxel followed by cisplatinum and 5-fluorouracil in patients with advanced solid tumors
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(7): 1723-1730 (1999)

Phase I and pharmacologic study of continuous infusion topotecan in combination with cisplatin in patients with advanced cancer: a Cancer and Leukemia Group B study
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 16(10): 3302-3309 (1998)

Phase I and pharmacologic study of high doses of the topoisomerase I inhibitor topotecan with granulocyte colony-stimulating factor in patients with solid tumors
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 14(4): 1224-1235 (1996)

Phase I and pharmacologic study of liposomal lurtotecan, NX 211: urinary excretion predicts hematologic toxicity
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(5): 1222-1231 (2002)

Phase I and pharmacologic study of oral (E)-2'-deoxy-2'-(fluoromethylene) cytidine: on a daily x 5-day schedule
, Investigational new Drugs 16(3): 245-254 (1998)

Phase I and pharmacologic study of oral ZD9331, a novel nonpolyglutamated thymidylate synthase inhibitor, in adult patients with solid tumors
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(7): 1923-1931 (2002)

Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 15(1): 187-192 (1997)

Phase I and pharmacologic study of sequential topotecan, carboplatin, and etoposide
, Lung Cancer 33(2-3): 241-248 (2001)

Phase I and pharmacologic study of weekly gemcitabine and paclitaxel in chemo-naïve patients with advanced non-small-cell lung cancer
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(7): 821-827 (2000)

Phase I and pharmacological study of CI-980, a novel synthetic antimicrotubule agent
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 3(3): 401-407 (1997)

Phase I and pharmacological study of a new camptothecin derivative, exatecan mesylate (DX-8951f), infused over 30 minutes every three weeks
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7(10): 3056-3064 (2001)

Phase I and pharmacological study of increased dose oral topotecan in combination with intravenous cisplatin
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(9): 1205-1207 (2000)

Phase I and pharmacological study of the novel topoisomerase I inhibitor 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11) administered as a ninety-minute infusion every 3 weeks
, Cancer Research 54(2): 427-436 (1994)

Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7(7): 1912-1922 (2001)

Phase I and pharmacological study of two schedules of the antifolate edatrexate in combination with cisplatin
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7(3): 501-509 (2001)

Phase I and pharmacological study of weekly administration of the polyamine synthesis inhibitor SAM 486A (CGP 48 664) in patients with solid tumors. European Organization for Research and Treatment of Cancer Early Clinical Studies Group
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(5): 1736-1743 (2000)

Phase I and pharmacological trial of fazarabine (Ara-AC) with granulocyte colony-stimulating factor
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 3(12 Pt 1): 2363-2370 (1997)

Phase I and pharmacology study of intoplicine (RP 60475; NSC 645008), novel topoisomerase I and II inhibitor, in cancer patients
, Anti-Cancer Drugs 7(2): 166-174 (1996)

Phase I and phase II metabolism of lithocholic acid in hepatic acinar zone 3 necrosis. Evaluation in rats by combined radiochromatography and gas-liquid chromatography-mass spectrometry
, Biochemical Pharmacology 48(6): 1187-1197 (1994)

Phase I and phase II xenobiotic biotransformation in different inbred strains of rats: study in immobilized perfused hepatocytes
, Folia Biologica 44(4): 127-132 (1998)

Phase I and phase II xenobiotic reactions and metabolism of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in aggregating liver cell cultures
, Biochemical Pharmacology 45(5): 1087-1096 (1993)

Phase I and subsequent phase II study of filgrastim (r-met-HuG-CSF) and dose intensified cyclophosphamide plus epirubicin in patients with non-Hodgkin's lymphoma and advanced solid tumors
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 10(8): 907-914 (1999)

Phase I cancer trials. A collusion of misunderstanding
, Hastings Center Report 30(4): 34-43 (2000)

Phase I cancer trials: a crucible of competing priorities
, International Anesthesiology Clinics 39(3): 13-33 (2001)

Phase I cancer trials: therapeutic research?
, Hastings Center Report 31(1): 4-5 (2001)

Phase I clinical and pharmacokinetic studies of the taxoid derivative RPR 109881A administered as a 1-hour or a 3-hour infusion in patients with advanced solid tumors
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(7): 1140-1150 (2002)

Phase I clinical and pharmacokinetic study of NSC 655649, a rebeccamycin analogue, given in both single-dose and multiple-dose formats
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(7): 2193-2201 (2002)

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(1): 83-94 (1999)

Phase I clinical and pharmacokinetic study of carzelesin (U-80244) given daily for five consecutive days
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2(10): 1717-1723 (1996)

Phase I clinical and pharmacokinetic study of flavopiridol administered as a daily 1-hour infusion in patients with advanced neoplasms
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(19): 4074-4082 (2002)

Phase I clinical and pharmacokinetic study of high-dose mitoxantrone combined with carboplatin, cyclophosphamide, and autologous bone marrow rescue: high response rate for refractory ovarian carcinoma
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 12(1): 176-183 (1994)

Phase I clinical and pharmacokinetic study of oral carboxyamidotriazole, a signal transduction inhibitor
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 15(2): 781-789 (1997)

Phase I clinical and pharmacokinetic study of oral penclomedine (NSC 338720) in adults with advanced solid malignancy
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(3): 706-711 (2002)

Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(16): 3533-3544 (2002)

Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(2): 390-396 (2000)

Phase I clinical and pharmacokinetic study of protein kinase C-alpha antisense oligonucleotide ISIS 3521 administered in combination with 5-fluorouracil and leucovorin in patients with advanced cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(4): 1042-1048 (2002)

Phase I clinical and pharmacokinetic study of the oral platinum analogue JM216 given daily for 14 days
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 9(12): 1315-1322 (1998)

Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(11): 2701-2708 (1998)

Phase I clinical and pharmacokinetic trial of irofulven
, Cancer ChemoTherapy and Pharmacology 48(6): 467-472 (2001)

Phase I clinical and pharmacologic study of chronic oral administration of the farnesyl protein transferase inhibitor R115777 in advanced cancer
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(11): 2726-2735 (2002)

Phase I clinical and pharmacologic trial of intravenous estramustine phosphate
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(4): 1115-1127 (2002)

Phase I clinical and pharmacological studies of 20-(S)-camptothecin and 20-(S)-9-nitrocamptothecin as anticancer agents
, Annals of the new York Academy of Sciences 803: 224-230 (1996)

Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitor
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(5): 1165-1175 (1998)

Phase I clinical and pharmacological study of O6-benzylguanine followed by carmustine in patients with advanced cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(8): 3025-3031 (2000)

Phase I clinical and pharmacological study of liposome-entrapped NDDP administered intrapleurally in patients with malignant pleural effusions
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 3(3): 373-379 (1997)

Phase I clinical and plasma and cellular pharmacological study of topotecan without and with granulocyte colony-stimulating factor
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2(9): 1489-1497 (1996)

Phase I clinical data on novel anticancer, antiangiogenesis drug
, Oncology 12(9): 1395 (1998)

Phase I clinical evaluation of [SP-4-3(R)]-[1,1-cyclobutanedicarboxylato(2-)](2-methyl-1,4- butanediamine-N,N1) platinum in patients with metastatic solid tumors
, Cancer ChemoTherapy and Pharmacology 31(4): 333-337 (1993)

Phase I clinical evaluation of a new iron oxide MR contrast agent
, Journal of Magnetic Resonance Imaging: Jmri 4(3): 301-307 (1994)

Phase I clinical study of 21-consecutive-day oral administration of etoposide
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(10): 1633-1639 (1994)

Phase I clinical study of 99mTc-MAG3
, Kaku Igaku. Japanese Journal of Nuclear Medicine 30(2): 181-188 (1993)

Phase I clinical study of SH L573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia and adult T-cell leukemia/lymphoma
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(5): 619-629 (1999)

Phase I clinical study of TT-62. Research group of TT-62
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(2): 241-246 (1993)

Phase I clinical study of a new anticancer drug boanmycin
, Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 18(2): 143-146 (1996)

Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(12): 3942-3947 (1999)

Phase I clinical study of oxaliplatin
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(12): 1899-1907 (1998)

Phase I clinical study of the recombinant oncotoxin TP40 in superficial bladder cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 1(1): 57-61 (1995)

Phase I clinical study on new vinca alkaloid derivative, KW-2307 (vinorelbine). KW-2307 Study Group
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(2): 177-187 (1994)

Phase I clinical study with 8-chloro-cAMP and evaluation of immunological effects in cancer patients
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 1(4): 377-384 (1995)

Phase I clinical trial design of anticancer agents--a Fibonacci and a modified Fibonacci sequence
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(5): 775-778 (2000)

Phase I clinical trial of RP 56976 (docetaxel) a new anticancer drug
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(12): 1997-2005 (1994)

Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound-guided fine-needle injection in patients with advanced pancreatic carcinoma
, Cancer 88(6): 1325-1335 (2000)

Phase I clinical trial of donor T-helper type-2 cells after immunoablative, reduced intensity allogeneic PBSC transplant
, CytoTherapy 4(5): 429-430 (2002)

Phase I clinical trial of interleukin 2 (IL-2) gene therapy for prostate cancer
, Current Urology Reports 2(1): 33 (2001)

Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 21(1): 143-147 (2003)

Phase I clinical trial of melphalan and 41.8 degrees C whole-body hyperthermia in cancer patients
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 15(1): 158-164 (1997)

Phase I clinical trial of perillyl alcohol administered daily
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(5): 1159-1164 (1998)

Phase I clinical trial of pyrazoloacridine NSC366140 (PD115934)
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 1(12): 1487-1493 (1995)

Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(18): 3772-3784 (2002)

Phase I clinical trial of serotherapy in patients with acute myeloid leukemia with an immunoglobulin M monoclonal antibody to CD15
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 1(9): 965-972 (1995)

Phase I clinical trial of the chimeric monoclonal antibody (c30.6) in patients with metastatic colorectal cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(12): 4674-4683 (2000)

Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2(4): 659-668 (1996)

Phase I clinical trial of weekly combined paclitaxel plus docetaxel in patients with solid tumors
, Cancer 89(11): 2309-2314 (2000)

Phase I clinical trial on adjuvant active immunotherapy of human gliomas with GD2-conjugate
, British Journal of Neurosurgery 16(3): 269-275 (2002)

Phase I clinical trial units in Spain: the current situation
, Methods and Findings in Experimental and Clinical Pharmacology 21(Suppl): 33-35 (1999)

Phase I clinical trial with HIV-1 gp160 plasmid vaccine in HIV-1-infected asymptomatic subjects
, European Journal of Clinical Microbiology and Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 20(11): 800-803 (2001)

Phase I clinical trials of tezacitabine [(E)-2'-deoxy-2'-(fluoromethylene)cytidine] in patients with refractory solid tumors
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(9): 2828-2834 (2002)

Phase I clinical trials: adapting methodology to face new challenges
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 5(Suppl): 67-70 (1994)

Phase I collaborative pilot study: Waste anesthetic gas levels in the PACU
, Journal of Perianesthesia Nursing: Official Journal of the American Society of Perianesthesia Nurses 17(4): 227-239 (2002)

Phase I dose de-escalation trial of alpha-difluoromethylornithine in patients with grade 3 cervical intraepithelial neoplasia
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(2): 303-310 (1998)

Phase I dose escalation study of gemcitabine and paclitaxel plus colony-stimulating factors in previously treated patients with advanced breast and ovarian cancer
, Clinical Oncology ) 12(4): 251-255 (2000)

Phase I dose escalation study of topotecan combined with alternating schedules of paclitaxel and carboplatin in advanced solid tumors
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(4): 549-555 (2001)

Phase I dose-escalating study of raltitrexed ('Tomudex') and cisplatin in metastatic non-small cell lung cancer
, Lung Cancer 36(2): 183-189 (2002)

Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy
, Cancer Journal from Scientific American 1(3): 204-209 (1995)

Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 11(10): 2021-2029 (1993)

Phase I dose-finding and pharmacokinetic study of docetaxel and vinorelbine as first-line chemotherapy for metastatic breast cancer
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(7): 909-918 (2001)

Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(11): 1631-1641 (2001)

Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(6): 2236-2244 (2000)

Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults
, Infection and Immunity 70(4): 2016-2021 (2002)

Analytical solution for bending vibration of a thin-walled cylinder rolling on a time-varying force
, Royal Society Open Science 5(7): 180639 (2018)

Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 3(3): 409-417 (1997)

Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphoma
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(13): 2995-3000 (2002)

Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(3): 674-679 (2002)

Phase I evaluation of therapy with four schedules of 5-fluorouracil by continuous infusion combined with recombinant interferon alpha
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 1(6): 615-620 (1995)

Phase I liarozole studies in advanced prostate cancer show encouraging results
, Oncology 8(6): 85 (1994)

Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas. Swiss Group for Clinical Research (SAKK)
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 9(8): 877-884 (1998)

Phase I multiple-dose administration study of exemestane in postmenopausal women
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(7): 1189-1197 (2002)

Phase I of the Stark II final rule
, Michigan Health and Hospitals 37(4): 52-53 (2001)

Phase I open study of the effects of ascending doses of the cytotoxic immunoconjugate CMB-401 (hCTMO1-calicheamicin) in patients with epithelial ovarian cancer
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(6): 735-741 (2000)

Phase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumors
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 21(2): 223-231 (2003)

Phase I pharmacokinetic study of the novel antitumor agent SR233377
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(8): 3088-3094 (2000)

Phase I pharmacokinetic trial and correlative in vitro phase II tumor kinetic study of Apomine (SR-45023A), a novel oral biphosphonate anticancer drug
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7(5): 1246-1250 (2001)

Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(8): 3071-3080 (2000)

Phase I pilot trial of the bispecific antibody MDXH210 (anti-Fc gamma RI X anti-HER-2/neu) in patients whose prostate cancer overexpresses HER-2/neu
, Journal of ImmunoTherapy 24(1): 79-87 (2001)

Phase I radioimmunotherapy of metastatic renal cell carcinoma with 131I-labeled chimeric monoclonal antibody G250
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(10 Suppl): 3268s-3274s (1999)

Phase I radioimmunotherapy trial with iodine-131--labeled humanized MN-14 anti-carcinoembryonic antigen monoclonal antibody in patients with metastatic gastrointestinal and colorectal cancer
, Clinical Colorectal Cancer 2(1): 31-42 (2002)

Phase I results of pullback atherectomy for hemodialysis access
, Journal of Vascular and Interventional Radiology: Jvir 5(4): 581-586 (1994)

Phase I safety and pharmacokinetic studies of brequinar sodium after single ascending oral doses in stable renal, hepatic, and cardiac allograft recipients
, Journal of Clinical Pharmacology 37(12): 1121-1128 (1997)

Phase I safety and pharmacokinetics study of micronized atovaquone in human immunodeficiency virus-infected infants and children. Pediatric AIDS Clinical Trials Group
, Antimicrobial Agents and ChemoTherapy 42(6): 1315-1318 (1998)

Phase I safety assessment of intrathecal injection of an American formulation of adenosine in humans
, Anesthesiology 96(1): 24-28 (2002)

Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(21): 4292-4302 (2002)

Phase I single-dose administration study of exemestane in postmenopausal women
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(7): 1179-1187 (2002)

Phase I studies in Spain: involvement of the multinational industry
, Methods and Findings in Experimental and Clinical Pharmacology 21(Suppl): 37 (1999)

Phase I studies of combined paclitaxel/epirubicin and paclitaxel/epirubicin/cyclophosphamide in patients with metastatic offast cancer: the French experience
, Seminars in Oncology 24(1 Suppl 3): S8-S12 (1997)

Phase I studies of nogitecan hydrochloride for Japanese
, International Journal of Clinical Oncology 7(3): 177-186 (2002)

Phase I studies of treatment of malignant gliomas and neoplastic meningitis with 131I-radiolabeled monoclonal antibodies anti-tenascin 81C6 and anti-chondroitin proteoglycan sulfate Me1-14 F (ab')2--a preliminary report
, Journal of Neuro-Oncology 24(1): 109-122 (1995)

Phase I studies with the nonclassical antifolate nolatrexed dihydrochloride (AG337, THYMITAQ) administered orally for 5 days
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(1): 111-118 (1999)

Phase I study of 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin (FCE 23762, PNU 152243) administered on a daily x3 schedule
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 8(8): 807-809 (1997)

Phase I study of 5-fluorouracil and l-leucovorin
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(4): 485-491 (1993)

Phase I study of 9-nitro-20(S)-camptothecin in combination with cisplatin for patients with advanced malignancies
, Annals of the new York Academy of Sciences 922: 345-348 (2000)

Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(5): 953-961 (1999)

Phase I study of BBR 2778, a new aza-anthracenedione, in advanced or refractory non-Hodgkin's lymphoma
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(5): 661-667 (2001)

Phase I study of CBT-1 and Taxol in patients with Taxol resistant cancers
, Cancer BioTherapy and Radiopharmaceuticals 15(2): 153-159 (2000)

Phase I study of CGS16949A--a new aromatase inhibitor. Cooperative Study Group for CGS16949A
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(2): 189-197 (1994)

Phase I study of Caelyx (doxorubicin HCL, pegylated liposomal) in recurrent or metastatic head and neck cancer
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(3): 339-342 (2000)

Phase I study of Doxil and vinorelbine in metastatic breast cancer
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 10(9): 1113-1116 (1999)

Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas
, Neuro-Oncology 3(4): 246-250 (2001)

Phase I study of MEN-10755, a new anthracycline in patients with solid tumours: a report from the European Organization for Research and Treatment of Cancer, Early Clinical Studies Group
, Annals of oncology: official journal of the European Society for Medical Oncology 13(3): 385-391 (2002)

Phase I study of N(1),N(11)-diethylnorspermine in patients with non-small cell lung cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(3): 684-690 (2002)

Phase I study of N-(phosphonacetyl)-L-aspartate with fluorouracil and with or without dipyridamole in patients with advanced cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2(7): 1107-1114 (1996)

Phase I study of ONO-4007, a synthetic analogue of the lipid A moiety of bacterial lipopolysaccharide
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(2): 397-405 (2000)

Phase I study of R24 in patients with metastatic melanoma including evaluation of immunologic parameters
, Cancer BioTherapy and Radiopharmaceuticals 13(1): 13-23 (1998)

Phase I study of S-1. S-1 Study Group
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(15): 2253-2264 (1997)

Phase I study of TAT-59 (a new antiestrogen) in breast cancer. TAT-59 Study Group
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(4): 553-561 (1998)

Phase I study of a combination chemotherapy of nedaplatin and cisplatin
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(14): 2209-2215 (1999)

Phase I study of a five-day dose schedule of 4-Ipomeanol in patients with non-small cell lung cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(9): 2095-2102 (1998)

Phase I study of a weekly infusion of irinotecan hydrochloride (CPT-11) and a 14-day continuous infusion of etoposide in patients with lung cancer: JCOG trial 9408
, Japanese Journal of Clinical Oncology 30(11): 487-493 (2000)

Phase I study of a weekly schedule of oxaliplatin, high-dose leucovorin, and infusional fluorouracil in pretreated patients with advanced colorectal cancer
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(5): 669-674 (2001)

Phase I study of adenoviral delivery of the HSV-tk gene and ganciclovir administration in patients with current malignant brain tumors
, Molecular Therapy: the Journal of the American Society of Gene Therapy 1(2): 195-203 (2000)

Phase I study of amrubicin hydrochroride (SM-5887) for superficial bladder cancer in intravesical chemotherapy
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(4): 475-482 (2001)

Phase I study of an antisense oligonucleotide to protein kinase C-alpha (ISIS 3521/CGP 64128A) in patients with cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(11): 3357-3363 (1999)

Phase I study of arabinosyl-5-azacytidine (fazarabine) in adult acute leukemia and chronic myelogenous leukemia in blastic phase
, Leukemia and Lymphoma 34(5-6): 511-518 (1999)

Phase I study of biweekly paclitaxel and carboplatin administration in patients with advanced non-small cell lung cancer
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(8): 1389-1394 (2002)

Phase I study of bryostatin 1: assessment of interleukin 6 and tumor necrosis factor alpha induction in vivo. The Cancer Research Campaign Phase I Committee
, Journal of the National Cancer Institute 85(22): 1812-1818 (1993)

Phase I study of carboplatin, docetaxel and irinotecan with recombinant human granulocyte colony stimulating factor support in patients with advanced non-small cell lung cancer
, Anti-Cancer Drugs 11(10): 821-824 (2000)

Phase I study of cinchonine, a multidrug resistance reversing agent, combined with the CHVP regimen in relapsed and refractory lymphoproliferative syndromes
, Leukemia 14(12): 2085-2094 (2000)

Phase I study of cisplatin and docetaxel plus mitomycin C in patients with metastatic non-small cell lung cancer
, Japanese Journal of Clinical Oncology 29(11): 546-549 (1999)

Phase I study of cisplatin, ifosfamide and CPT11 with granulocyte colony-stimulating factor support in advanced non-small cell lung cancer
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(10): 1285-1290 (1996)

Phase I study of cladribine (2-chlorodeoxyadenosine) in lymphoid malignancies. Cladribine Study Group
, Japanese Journal of Clinical Oncology 27(3): 146-153 (1997)

Phase I study of combination chemotherapy with 5-fluorouracil (5-FU) and nedaplatin (NDP): adverse effects and eecommended dose of NDP administered after 5-FU
, American Journal of Clinical Oncology 25(6): 565-569 (2002)

Phase I study of combination topotecan and carboplatin in pediatric solid tumors
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(1): 88-95 (2002)

Phase I study of combined alpha interferon, alpha difluoromethylornithine (DFMO), and doxorubicin in advanced malignancy
, Investigational new Drugs 12(1): 25-27 (1994)

Phase I study of combined radiation, hyperthermia and intra-arterial carboplatin for local recurrence of cervical cancer
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 14(2): 298-303 (2003)

Phase I study of concomitant gemcitabine and IMRT for patients with unresectable adenocarcinoma of the pancreatic head
, International Journal of Gastrointestinal Cancer 30(3): 123-132 (2001)

Phase I study of continuous-infusion recombinant macrophage colony-stimulating factor in patients with metastatic melanoma
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2(2): 295-302 (1996)

Phase I study of daily times five topotecan and single injection of cisplatin in patients with previously untreated non-small-cell lung carcinoma
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 8(10): 1003-1008 (1997)

Phase I study of direct administration of a replication deficient adenovirus vector containing the E. coli cytosine deaminase gene to metastatic colon carcinoma of the liver in association with the oral administration of the pro-drug 5-fluorocytosine
, Human Gene Therapy 8(8): 985-1001 (1997)

Phase I study of direct intralesional gene transfer of HLA-B7 into metastatic renal carcinoma lesions
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(10): 2766-2772 (1999)

Phase I study of docetaxel administered by bi-weekly infusion to patients with metastatic breast cancer
, Anticancer Research 20(6c): 4721-4726 (2000)

Phase I study of doxil-cisplatin combination chemotherapy in patients with advanced malignancies
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7(10): 3040-3046 (2001)

Phase I study of edobacomab (E5) in patients with gram-negative sepsis
, Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 68(1): 59-80 (1994)

Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(2): 291-298 (1999)

Phase I study of escalating does of carboplatin
, Cancer ChemoTherapy and Pharmacology 34(6): 535-536 (1994)

Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(2): 275-279 (1999)

Phase I study of etoposide phosphate (etopophos) as a 30-minute infusion on days 1, 3, and 5
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 1(1): 105-111 (1995)

Phase I study of fludarabine and paclitaxel for the treatment of low-grade non-Hodgkin's lymphoma
, Leukemia and Lymphoma 26(1-2): 77-82 (1997)

Phase I study of fludarabine plus cyclophosphamide in patients with previously untreated low-grade lymphoma: results and and long-term follow-up--a report from the Eastern Cooperative Oncology Group
, Journal of clinical oncology: official journal of the American Society of Clinical Oncology 18(5): 987-994 (2000)

Phase I study of gemcitabine (GEM) and docetaxel (TXT) combination chemotherapy for unresectable non-small-cell lung cancer
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(11): 1929-1933 (2002)

Phase I study of gemcitabine (difluorodeoxycytidine) in children with relapsed or refractory leukemia (CCG-0955): a report from the Children's Cancer Group
, Leukemia and Lymphoma 43(10): 1945-1950 (2002)

Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma
, Lung Cancer 32(2): 189-196 (2001)

Phase I study of gemcitabine hydrochloride (LY 188011) combination therapy with cisplatin in the patients with non-small cell lung cancer
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(7): 898-907 (1999)

Phase I study of hyperfractionated whole brain irradiation (HWBI) in the treatment of primary cerebral lymphoma
, Clinical Oncology ) 5(3): 159-164 (1993)

Phase I study of immunotherapy of hepatic metastases of colorectal carcinoma by direct gene transfer
, Human Gene Therapy 5(11): 1385-1399 (1994)

Phase I study of immunotherapy of malignant melanoma by direct gene transfer
, Human Gene Therapy 5(11): 1371-1384 (1994)

Phase I study of immunotherapy of metastatic renal cell carcinoma by direct gene transfer into metastatic lesions
, Human Gene Therapy 5(11): 1357-1370 (1994)

Phase I study of intraperitoneal metalloproteinase inhibitor BB94 in patients with malignant ascites
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(8): 1899-1902 (1998)

Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(12): 3686-3695 (2002)

Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(3): 513-520 (1999)

Phase I study of intravenous Lu-labeled CC49 murine monoclonal antibody in patients with advanced adenocarcinoma
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 1(12): 1447-1454 (1995)

Phase I study of irinotecan and concurrent radiation therapy for upper GI tumors
, Oncology 14(12 Suppl 14): 34-37 (2000)

Phase I study of irinotecan combined with carboplatin in previously untreated solid cancers
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(12): 3963-3969 (1999)

Phase I study of irinotecan in pediatric patients with malignant solid tumors
, Journal of Pediatric Hematology/Oncology 24(2): 94-100 (2002)

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2(3): 483-491 (1996)

Phase I study of mitoxantrone plus etoposide with multidrug blockade by SDZ PSC-833 in relapsed or refractory acute myelogenous leukemia
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 15(5): 1796-1802 (1997)

Phase I study of orally administered UFT plus l-leucovorin
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(4): 531-539 (1998)

Phase I study of paclitaxel
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(14): 2407-2414 (1994)

Phase I study of paclitaxel (Taxol) and ifosfamide in previously untreated patients with advanced non-small-cell lung cancer. A study of the National Cancer Institute of Canada Clinical Trials Group
, Annals of oncology: official journal of the European Society for Medical Oncology 7(3): 311-313 (1996)

Phase I study of paclitaxel (Taxol) plus vinorelbine (Navelbine) in patients with untreated stage IIIb and IV non-small cell lung cancer
, Lung Cancer 31(2-3): 295-301 (2001)

Phase I study of paclitaxel administered as a 1-hour infusion: toxicity and pharmacokinetics
, Seminars in Oncology 24(6 Suppl 19): S19 (1997)

Phase I study of paclitaxel and oral etoposide in previously untreated non-small-cell and extensive small-cell lung cancer
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 8(5): 485-489 (1997)

Phase I study of paclitaxel with oral etoposide in advanced solid tumors
, Cancer Journal from Scientific American 2(5): 286-290 (1996)

Phase I study of pegylated liposomal doxorubicin, paclitaxel, and cisplatin in patients with advanced solid tumors
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(12): 1743-1747 (2001)

Phase I study of percutaneous cryotherapy for colorectal liver metastasis
, British Journal of Surgery 89(3): 303-310 (2002)

Phase I study of perillyl alcohol in patients with refractory malignancies
, Cancer Biology and Therapy 1(2): 130-135 (2002)

Phase I study of prolonged infusion Bryostatin-1 in patients with advanced malignancies
, Cancer Biology and Therapy 1(4): 409-416 (2002)

Phase I study of raltitrexed (ZD-1694)
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(13): 2075-2084 (1998)

Phase I study of recombinant CEA vaccinia virus vaccine with post vaccination CEA peptide challenge
, Human Gene Therapy 7(11): 1381-1394 (1996)

Phase I study of recombinant human endostatin in patients with advanced solid tumors
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(18): 3792-3803 (2002)

Phase I study of recombinant interleukin-1 beta in patients undergoing autologous bone marrow transplant for acute myelogenous leukemia
, Blood 83(12): 3473-3479 (1994)

Phase I study of rubitecan and gemcitabine in patients with advanced malignancies
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(11): 1819-1825 (2002)

Phase I study of second-line chemotherapy with docetaxel and carboplatin in advanced non-small-cell lung cancer
, Cancer ChemoTherapy and Pharmacology 48(6): 446-450 (2001)

Phase I study of subcutaneously administered recombinant human interleukin 12 in patients with advanced renal cell cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(12): 3983-3989 (1999)

Phase I study of super high-dose chemotherapy for liver cancer with percutaneous isolated hepatic perfusion (PIHP) and peripheral blood stem cell transplantation (PBSCT)
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(12): 1801-1804 (2000)

Phase I study of suramin administered by intermittent infusion without adaptive control to cancer patients: update of two expanded dose levels near the maximally tolerated dose
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 14(9): 2622-2623 (1996)

Phase I study of suramin combined with doxorubicin in the treatment of androgen-independent prostate cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(5): 1193-1201 (1998)

Phase I study of temozolomide in paediatric patients with advanced cancer. United Kingdom Children's Cancer Study Group
, British Journal of Cancer 78(5): 652-661 (1998)

Phase I study of temozolomide in relapsed/refractory acute leukemia
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(15): 3249-3253 (2002)

Phase I study of the antineovascularization drug CM101
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 3(3): 365-372 (1997)

Phase I study of the antipurine antifolate lometrexol (DDATHF) with folinic acid rescue
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2(7): 1123-1127 (1996)

Phase I study of the combination of gemcitabine and nedaplatin for treatment of previously untreated advanced non-small cell lung cancer
, Lung Cancer 39(1): 91-97 (2003)

Phase I study of the cyclin-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumors
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(8): 2157-2170 (2002)

Phase I study of the cytotoxic agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide
, Cancer ChemoTherapy and Pharmacology 44(1): 39-44 (1999)

Phase I study of the duocarmycin semisynthetic derivative KW-2189 given daily for five days every six weeks
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(9): 2111-2117 (1998)

Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(1): 142-152 (2002)

Phase I study of the matrix metalloproteinase inhibitor, BAY 12-9566
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(3): 389-395 (2001)

Phase I study of the novel cyclic AMP (cAMP) analogue 8-chloro-cAMP in patients with cancer: toxicity, hormonal, and immunological effects
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(7): 1682-1689 (1999)

Phase I study of the orally administered butyrate prodrug, tributyrin, in patients with solid tumors
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(3): 629-634 (1998)

Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(11): 2691-2700 (1998)

Phase I study of the sequential administration of edatrexate and paclitaxel in patients with advanced solid tumors
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 10(5): 601-603 (1999)

Phase I study of the somatostatin analogue somatuline in refractory small-cell lung carcinoma
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 5(3): 290-291 (1994)

Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeks
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7(12): 3963-3970 (2001)

Phase I study of topotecan administered as a 21-day continous infusion in children with recurrent solid tumors: a report from the Children's Cancer Group
, Clinical cancer research: an official journal of the American Association for Cancer Research 5(12): 3956-3962 (1999)

Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositis
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(6): 1363-1368 (1999)

Phase I study of twelve-day prolonged infusion of high-dose ifosfamide and doxorubicin as first-line chemotherapy in adult patients with advanced soft tissue sarcomas
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(1): 161-166 (2002)

Phase I study of weekly CPT-11 (irinotecan)/docetaxel in patients with advanced solid tumors
, Lung Cancer 37(2): 213-218 (2002)

Phase I study of weekly oxaliplatin plus irinotecan in previously treated patients with metastatic colorectal cancer
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(9): 1490-1496 (2002)

Phase I study on DMDC
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(13): 1799-1811 (1996)

Phase I study on infusion of PJ-203 (degradable starch microspheres) into hepatic. PJ-203 Clinical Study Group
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(12): 1817-1825 (1993)

Phase I study on sentinel lymph node mapping in colon cancer: a preliminary report
, Journal of surgical oncology 79(2): 81 (2002)

Phase I study with irinotecan hydrochloride (CPT-11) for advanced neuroblastoma
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(13): 2049-2054 (2001)

Phase I study with pharmacokinetics of S-1 on an oral daily schedule for 28 days in patients with solid tumors
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 9(1): 134-142 (2003)

Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapy in patients with carcinoma of the cervix uteri
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(4): 455-459 (2000)

Phase I targeted systemic exposure study of paclitaxel in children with refractory acute leukemias
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(3): 543-549 (1999)

Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck
, Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 41(12): 1999-2010 (2000)

Phase I therapy trials in children with cancer
, Journal of Pediatric Hematology/Oncology 20(5): 431-438 (1998)

Phase I treatment
, American Journal of Orthodontics and Dentofacial Orthopedics: Official Publication of the American Association of Orthodontists its Constituent Societies and the American Board of Orthodontics 111(2): 239-240 (1997)

Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-B-D-arabinofuranosylcytosine in patients with refractory acute leukemia
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(7): 2123-2133 (2002)

Phase I trial and pharmacokinetic (PK) and pharmacodynamics (PD) study of topotecan using a five-day course in children with refractory solid tumors: a pediatric oncology group study
, Journal of Pediatric Hematology/Oncology 18(4): 352-361 (1996)

Phase I trial design: are new methodologies being put into practice?
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 7(6): 561-566 (1996)

Phase I trial dosing of gemcitabine and concurrent involved field irradiation in patients with localized pancreatic carcinomas
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 17(11): 3692 (1999)

Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(19): 3983-3991 (2002)

Phase I trial for AG1343
, Aids Patient Care 9(1): 40 (1995)

Phase I trial of 1alpha-hydroxyvitamin d(2) in patients with hormone refractory prostate cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(9): 2820-2827 (2002)

Phase I trial of 9-cis retinoic acid in adults with solid tumors
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2(2): 287-293 (1996)

Phase I trial of 96-hour continuous infusion of dexrazoxane in patients with advanced malignancies
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7(6): 1569-1576 (2001)

Phase I trial of Adozelesin using the treatment schedule of daily x5 every 3 weeks
, Investigational new Drugs 13(4): 321-326 (1996)

Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patients with advanced cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(3): 679-683 (2002)

Phase I trial of HuM291, a humanized anti-CD3 antibody, in patients receiving renal allografts from living donors
, Transplantation 70(12): 1707-1712 (2000)

Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 16(6): 2150-2156 (1998)

Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(5): 1744-1754 (2000)

Phase I trial of XR9576 in healthy volunteers demonstrates modulation of P-glycoprotein in CD56+ lymphocytes after oral and intravenous administration
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(11): 4186-4191 (2000)

Phase I trial of a 24-h continuous infusion of ifosfamide/mesna in acute lymphoblastic leukemia
, Journal of Experimental Therapeutics and Oncology 1(2): 84-87 (1996)

Phase I trial of a 90-minute infusion of the fusion toxin DAB486IL-2 in hematological cancers
, Cancer Research 53(17): 3930-3934 (1993)

Phase I trial of a MART-1 peptide vaccine with incomplete Freund's adjuvant for resected high-risk melanoma
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(10): 2756-2765 (1999)

Phase I trial of a genetically engineered interleukin-2 fusion toxin (DAB486IL-2) as a 6 hour intravenous infusion in patients with hematologic malignancies
, Leukemia and Lymphoma 14(3-4): 257-262 (1994)

Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7(10): 3012-3024 (2001)

Phase I trial of a novel diphtheria toxin/granulocyte macrophage colony-stimulating factor fusion protein (DT388GMCSF) for refractory or relapsed acute myeloid leukemia
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(5): 1004-1013 (2002)

Phase I trial of adoptive immunotherapy with cytolytic T lymphocytes immunized against a tyrosinase epitope
, Journal of clinical oncology: official journal of the American Society of Clinical Oncology 20(14): 3176; author reply 3176-7 (2002)

Phase I trial of all-trans retinoic acid in patients with treated head and neck squamous carcinoma
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(3): 847-854 (2000)

Phase I trial of an infrared pulsed laser device in patients with advanced neoplasias
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(10): 3082-3091 (2002)

Phase I trial of anti-B4-blocked ricin in pediatric patients with leukemia and lymphoma
, Journal of ImmunoTherapy 24(6): 511-516 (2001)

Phase I trial of capecitabine in combination with interferon alpha in patients with metastatic renal cancer: toxicity and pharmacokinetics
, Cancer ChemoTherapy and Pharmacology 48(6): 493-498 (2001)

Phase I trial of cisplatin and topotecan in children with recurrent solid tumors: Children's Cancer Group Study 0942
, Journal of Pediatric Hematology/Oncology 24(2): 89-93 (2002)

Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(4): 1267-1272 (2000)

Phase I trial of concurrent thoracic radiation and continuous infusion cisplatin and etoposide in stage III non-small cell lung cancer
, Lung Cancer 25(3): 175-182 (1999)

Phase I trial of cremophor EL with bolus doxorubicin
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(10): 2321-2329 (1998)

Phase I trial of cyclophosphamide, doxorubicin, and 5-fluorouracil plus interferon-alpha 2b in patients with advanced breast cancer
, Cancer Research 53(15): 3509-3512 (1993)

Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 16(6): 2164-2168 (1998)

Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma
, Cancer 88(5): 1045-1050 (2000)

Phase I trial of docetaxel with filgrastim support in pediatric patients with refractory solid tumors: a collaborative Pediatric Oncology Branch, National Cancer Institute and Children's Cancer Group trial
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(4): 733-737 (1999)

Phase I trial of dolastatin-10 (NSC 376128) in patients with advanced solid tumors
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(3): 525-531 (1999)

Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(1): 78-89 (2000)

Phase I trial of gemcitabine (Gemzar), 24 h infusion 5-fluorouracil and folinic acid in patients with inoperable pancreatic cancer
, Anti-Cancer Drugs 10(8): 699-704 (1999)

Phase I trial of gemcitabine and CPT-11 given weekly for four weeks every six weeks
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(5): 627-631 (2001)

Phase I trial of gemcitabine and carboplatin in metastatic non-small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie Study
, Lung Cancer 36(2): 191-198 (2002)

Phase I trial of gemcitabine and cisplatin in advanced non-small cell lung cancer: a preliminary report
, Lung Cancer 14(1): 135-144 (1996)

Phase I trial of gemcitabine combined with radiation for the treatment of locally advanced pancreatic adenocarcinoma
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7(8): 2246-2253 (2001)

Phase I trial of inhaled natural interleukin 2 for treatment of pulmonary malignancy: toxicity, pharmacokinetics, and biological effects
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2(7): 1115-1122 (1996)

Phase I trial of interleukin 2 in combination with the soluble tumor necrosis factor receptor p75 IgG chimera
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2(8): 1341-1351 (1996)

Phase I trial of intoplicine (RP 60475) administered as a 72 h infusion every 3 weeks in patients with solid tumors
, Anti-Cancer Drugs 10(10): 889-894 (1999)

Phase I trial of intraperitoneal injection of the E1B-55-kd-gene-deleted adenovirus ONYX-015 (dl1520) given on days 1 through 5 every 3 weeks in patients with recurrent/refractory epithelial ovarian cancer
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(6): 1562-1569 (2002)

Phase I trial of intratumoral liposome E1A gene therapy in patients with recurrent breast and head and neck cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7(5): 1237-1245 (2001)

Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(9): 2251-2266 (2002)

Phase I trial of intravenous carboplatin and cyclosporin A in refractory gynecologic cancer patients
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2(10): 1699-1704 (1996)

Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 11(3): 478-484 (1993)

Phase I trial of intravesical gemcitabine in bacillus Calmette-Guérin-refractory transitional-cell carcinoma of the bladder
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(15): 3193-3198 (2002)

Phase I trial of irinotecan and epirubicin in advanced cancer. Preliminary report
, Oncology 16(8 Suppl 7): 17-19 (2002)

Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society
, Clinical cancer research: an official journal of the American Association for Cancer Research 5(4): 753-759 (1999)

Phase I trial of novel HER-2 vaccine for breast cancer initiated
, Expert Review of Anticancer Therapy 2(5): 483 (2002)

Phase I trial of oral 2'-deoxy-2'-methylidenecytidine: on a daily x 14-day schedule
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(6): 2288-2294 (2000)

Phase I trial of orally administered pentosan polysulfate in patients with advanced cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 3(12 Pt 1): 2347-2354 (1997)

Phase I trial of outpatient weekly docetaxel, carboplatin and concurrent thoracic radiation therapy for stage III unresectable non-small-cell lung cancer: a Vanderbilt cancer center affiliate network (VCCAN) trial
, Lung Cancer 34(3): 441-449 (2001)

Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 12(12): 2682-2686 (1994)

Phase I trial of paclitaxel and etoposide for recurrent ovarian carcinoma: a Gynecologic Oncology Group Study
, American Journal of Clinical Oncology 23(6): 609-613 (2000)

Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 9(7): 733-738 (1998)

Phase I trial of paclitaxel plus megestrol acetate in patients with paclitaxel-refractory ovarian cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(11): 4201-4204 (2000)

Phase I trial of recombinant human granulocyte-macrophage colony stimulating factor. Results in patients with advanced tumors
, Bulletin du Cancer 80(5): 418-430 (1993)

Phase I trial of recombinant interleukin 3 before and after carboplatin/etoposide chemotherapy in patients with solid tumors: a southwest oncology group study
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 1(10): 1139-1144 (1995)

Phase I trial of sequential administration of raltitrexed (Tomudex) and 5-iodo-2'-deoxyuridine (IdUrd)
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(5): 701-707 (2001)

Phase I trial of sequential high-dose chemotherapy with escalating dose paclitaxel, melphalan, and cyclophosphamide, thiotepa, and carboplatin with peripheral blood progenitor support in women with responding metastatic breast cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(7): 1689-1695 (1998)

Phase I trial of simultaneous administration of interleukin 2 and interleukin 4 subcutaneously
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 1(10): 1145-1152 (1995)

Phase I trial of simultaneously administered GM-CSF and IL-6 in patients with renal-cell carcinoma: clinical and laboratory effects
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(5): 655-659 (2001)

Phase I trial of strictly time-scheduled gemcitabine and cisplatin with concurrent radiotherapy in patients with locally advanced pancreatic cancer
, International Journal of Radiation Oncology Biology Physics 55(1): 144-153 (2003)

Phase I trial of subcutaneous interleukin 3 in patients with refractory malignancy: hematological, immunological, and pharmacodynamic findings
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2(2): 347-357 (1996)

Phase I trial of subcutaneous interleukin-1 alpha in children with malignant solid tumors
, Medical and Pediatric Oncology 28(6): 444-450 (1997)

Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(5): 1183-1191 (1998)

Phase I trial of sulindac plus 5-fluorouracil and levamisole: potential adjuvant therapy for colon carcinoma
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2(1): 37-41 (1996)

Phase I trial of sulofenur (LY186641) given orally on a daily x 21 schedule
, Anti-Cancer Drugs 5(2): 151-159 (1994)

Phase I trial of technetium [Leu13] bombesin as cancer seeking agent: possible scintigraphic guide for surgery?
, Tumori 88(3): S28-S30 (2002)

Phase I trial of temozolomide (NSC 362856) in patients with advanced cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 3(7): 1093-1100 (1997)

Phase I trial of the angiogenesis inhibitor TNP-470 for progressive androgen-independent prostate cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7(5): 1198-1203 (2001)

Phase I trial of the colloidal dispersion formulation of 9-amino-20(S)-camptothecin administered as a 72-hour continuous intravenous infusion
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(2): 317-324 (1998)

Phase I trial of the combination of daily estramustine phosphate and intermittent docetaxel in patients with metastatic hormone refractory prostate carcinoma
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 10(1): 33-38 (1999)

Phase I trial of the cryptophycin analogue LY355703 administered as an intravenous infusion on a day 1 and 8 schedule every 21 days
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(8): 2524-2529 (2002)

Phase I trial of the diphtheria toxin/interleukin-2 fusion protein DAB486IL-2: efficacy in mycosis fungoides and other non-Hodgkin's lymphomas
, Leukemia and Lymphoma 11(5-6): 369-377 (1993)

Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(3): 718-728 (2002)

Phase I trial of the hypoxic cell cytotoxin tirapazamine with concurrent radiation therapy in the treatment of refractory solid tumors
, International Journal of Radiation Oncology Biology Physics 44(2): 349-353 (1999)

Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(22): 4420-4427 (2002)

Phase I trial of the recombinant soluble complement receptor 1 in acute lung injury and acute respiratory distress syndrome
, Critical Care Medicine 28(9): 3149-3154 (2000)

Phase I trial of the selective mitochondrial toxin MKT077 in chemo-resistant solid tumours
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 10(8): 923-927 (1999)

Phase I trial of the thymidylate synthase inhibitor AG331 as a 5-day continuous infusion
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2(10): 1685-1692 (1996)

Phase I trial of twice-weekly intravenous interleukin 12 in patients with metastatic renal cell cancer or malignant melanoma: ability to maintain IFN-gamma induction is associated with clinical response
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(5): 1678-1692 (2000)

Phase I trial of weekly docetaxel combined with cisplatin in patients with non-small cell lung cancer
, Lung Cancer 34(1): 125-131 (2001)

Phase I trial of weekly docetaxel in elderly patients with non-small cell lung cancer
, Lung Cancer 38(2): 205-209 (2002)

Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small-cell lung cancer
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(3): 804-810 (2002)

Phase I trials in Israel: some considerations
, Israel Medical Association Journal: Imaj 2(6): 478-479 (2000)

Phase I trials in cancer patients: participants' perceptions
, European Journal of Cancer Care 7(1): 15-22 (1998)

Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(4): 546-552 (2002)

Phase I-II and pharmacokinetic study of a new fotemustine schedule in advanced non-small cell lung cancer
, Lung Cancer 13(1): 69-78 (1995)

Phase I-II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(9): 1479-1489 (2002)

Phase I-II study of dose intensified chemotherapy with filgrastim and thymopentin in patients with advanced cancer
, La Clinica Terapeutica 148(5-6): 201-207 (1997)

Phase I-II study of gamma interferon and 5-fluorouracil for patients with metastatic renal cell carcinoma
, Cancer BioTherapy and Radiopharmaceuticals 12(6): 365-370 (1997)

Phase I-II study of gemcitabine and paclitaxel in pretreated patients with stage IIIB-IV non-small cell lung cancer
, Lung Cancer 30(3): 203-210 (2000)

Phase I-II study of irinotecan combined with mitomycin-C in patients with advanced gastric cancer
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(12): 1729-1735 (2001)

Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 18(18): 3247-3255 (2000)

Phase I-II study of pegylated liposomal cisplatin (SPI-077) in patients with inoperable head and neck cancer
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(4): 493-496 (2001)

Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 8(9): 865-870 (1997)

Phase I-II trial of concomitant continuous carboplatin (CBDCA) infusion and radiotherapy in advanced nonsmall cell lung cancer with evaluation for surgery: final report
, International Journal of Radiation Oncology Biology Physics 37(1): 93-101 (1997)

Phase I-II vinorelbine (Navelbine) by continuous infusion in patients with metastatic breast cancer: cumulative toxicities limit dose escalation
, Cancer Investigation 19(5): 459-466 (2001)

Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcoma
, Human Gene Therapy 8(7): 875-891 (1997)

Phase I/II 90Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma
, European Journal of Nuclear Medicine 27(7): 766-777 (2000)

Phase I/II and pharmacologic study of irinotecan and carboplatin for patients with lung cancer
, Cancer ChemoTherapy and Pharmacology 48(6): 481-487 (2001)

Phase I/II and pharmacologic study of long-term continuous infusion etoposide combined with cisplatin in patients with advanced non-small-cell lung cancer
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 12(1): 83-89 (1994)

Phase I/II dose finding study of paclitaxel and carboplatin in advanced non-small cell lung cancer
, Lung Cancer 25(1): 39-46 (1999)

Phase I/II dose-escalation study of liarozole in patients with stage D, hormone-refractory carcinoma of the prostate
, Annals of Surgical Oncology 2(6): 550-556 (1995)

Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(11): 2729-2739 (1998)

Phase I/II studies of docetaxel (Taxotere) combined with estramustine in men with hormone-refractory prostate cancer
, Seminars in Oncology 26(5 Suppl 17): 28-33 (1999)

Phase I/II studies of isolated hepatic perfusion with mitomycin C or melphalan in patients with colorectal cancer hepatic metastases
, Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 147: 83-94 (1998)

Phase I/II study of 3TC (lamivudine) in HIV-positive, asymptomatic or mild AIDS-related complex patients: sustained reduction in viral markers. The Lamivudine European HIV Working Group
, Aids 9(12): 1323-1329 (1995)

Phase I/II study of G17-DT, an anti-gastrin immunogen, in advanced colorectal cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(12): 4719-4724 (2000)

Phase I/II study of a combination regimen composed of cisplatin, carboplatin and etoposide against small cell lung cancer
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(16): 2787-2791 (1994)

Phase I/II study of combination chemotherapy with cisplatin, carboplatin and etoposide in small cell lung cancer
, Lung Cancer 15(2): 225-232 (1996)

Phase I/II study of concurrent weekly carboplatin and radiation therapy in advanced head and neck cancer
, Clinical Oncology ) 5(3): 133-138 (1993)

Phase I/II study of intraperitoneal mitoxantrone in refractory ovarian cancer
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 5(4): 343-347 (1994)

Phase I/II study of neoadjuvant intraarterial chemotherapy with mitomycin-C, vincristine, and cisplatin in patients with stage IIb bulky cervical carcinoma
, Cancer 76(5): 814-823 (1995)

Phase I/II study of paclitaxel, gemcitabine and vinorelbine as first-line chemotherapy of non-small-cell lung cancer
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(12): 1862-1867 (2002)

Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer
, Seminars in Oncology 24(6 Suppl 19): S19 (1997)

Phase I/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 16(7): 2514-2521 (1998)

Phase I/II study of the combination of carboplatin and paclitaxel as first-line chemotherapy in patients with advanced epithelial ovarian cancer
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 8(4): 355-361 (1997)

Phase I/II study of weekly irinotecan and paclitaxel in patients with SCLC
, Oncology 14(7 Suppl 5): 63-66 (2000)

Phase I/II study with a weekly 24-hour infusion of 5-fluorouracil plus high-dose folinic acid (HD-FU/FA) in intensively pretreated patients with metastatic breast cancer
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 7(1): 55-58 (1996)

Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report
, International Journal of Radiation Oncology Biology Physics 51(3): 605-613 (2001)

Phase I/II trial of batimastat, a matrix metalloproteinase inhibitor, in patients with malignant ascites
, European Journal of Surgical Oncology: the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 23(6): 526-531 (1997)

Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies. Nagoya CD34+ PBSCT Study Group
, Cancer ChemoTherapy and Pharmacology 40(Suppl): S51-S57 (1997)

Phase I/II trial of docetaxel and vinorelbine in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy
, Lung Cancer 34(1): 105-113 (2001)

Phase I/II trial of gemcitabine plus cyclophosphamide in patients with metastatic breast carcinoma previously treated with taxanes
, Clinical Breast Cancer 2(4): 299-303 (2002)

Phase I/II trial of irinotecan, carboplatin, and paclitaxel in advanced or metastatic NSCLC
, Oncology 14(7 Suppl 5): 29-34 (2000)

Phase I/II trial of low dose cyclosporin A with EP for advanced non-small cell lung cancer
, Lung Cancer 18(2): 189-198 (1997)

Phase I/II trial of multiple dose 131Iodine-MAb LL2 (CD22) in patients with recurrent non-Hodgkin's lymphoma
, Leukemia and Lymphoma 38(1-2): 91-101 (2000)

Phase I/II trial of radiation with chemotherapy "boost" for advanced squamous cell carcinomas of the head and neck: toxicities and responses
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 17(8): 2390-2395 (1999)

Phase I/II trial with fozivudine tidoxil (BM 21.1290): a 7 day randomized, placebo-controlled dose-escalating trial
, Antiviral Therapy 2(4): 257-264 (1997)

Phase I/IIa study of concurrent paclitaxel and cisplatin with radiation therapy in locally advanced non-small cell lung cancer: analysis of early and late pulmonary morbidity
, Seminars in Radiation Oncology 9(2 Suppl 1): 136-147 (1999)

Phase I/pharmacokinetic study of the topoisomerase I inhibitor GG211 administered as a 21-day continuous infusion
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 10(3): 339-344 (1999)

Phase IB clinical trial of the oligosaccharide processing inhibitor swainsonine in patients with advanced malignancies
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 3(7): 1077-1086 (1997)

Phase IB study of 25-hydroxyvitamin D(3) treatment to diminish suppressor cells in head and neck cancer patients
, Human Immunology 62(11): 1282-1293 (2001)

Phase IB study on prevention of surgery-induced immunodeficiency with preoperative administration of low-dose subcutaneous interleukin-2 in gastric cancer patients
, Journal of Surgical Oncology 78(1): 32-37 (2001)

Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 3(8): 1277-1288 (1997)

Phase II EORTC trial with 5-fluorouracil, cisplatin and interferon-alpha as second-line treatment of advanced transitional cell cancer of the urothelial tract
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(11): 1391-1394 (2000)

Phase II Trial of Paclitaxel in Patients with Advanced Colon Cancer Previously Untreated with Cytotoxic Chemotherapy: An Eastern Cooperative Oncology Group Trial (PA286)
, American Journal of Therapeutics 3(11): 750-754 (1996)

Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(6): 1593-1599 (2002)

Phase II ambulatory cardiac rehabilitation (Cologne model). 3 year results after conclusion of the intervention
, MMW Fortschritte der Medizin 142(3 Suppl): 173-177 (2000)

Phase II and III clinical trials of toremifene for metastatic breast cancer
, Oncology 12(3 Suppl 5): 9-13 (1998)

Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment
, Anticancer Research 19(5c): 4379-4390 (1999)

Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(2): 364-370 (2002)

Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(4): 929-934 (1998)

Phase II and pharmacokinetic study of fotemustine in inoperable colorectal cancer
, European Journal of Cancer 29a(2): 288-289 (1993)

Phase II and pharmacologic study of weekly oral paclitaxel plus cyclosporine in patients with advanced non-small-cell lung cancer
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(23): 4508-4516 (2002)

Phase II begins for T-20
, AIDS patient care and STDs 13(9): 567-568 (1999)

Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 1(7): 691-697 (1995)

Phase II clinical study of 99mTc-MAG3
, Kaku Igaku. Japanese Journal of Nuclear Medicine 30(4): 411-422 (1993)

Phase II clinical study of RP56976 (docetaxel) in patients with carcinoma ovarii or carcinoma colli uteri
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(14): 2471-2477 (1994)

Phase II clinical study of SH L 573 (fludarabine phosphate) in patients with chronic lymphocytic leukemia
, Japanese Journal of Clinical Hematology 40(12): 1236-1244 (1999)

Phase II clinical study of a new anticancer drug boanmycin
, Zhongguo Yi Xue Ke Xue Yuan Xue Bao. Acta Academiae Medicinae Sinicae 21(4): 247-251 (1999)

Phase II clinical study of recombinant human erythropoietin on the anemia associated with multiple myeloma
, Japanese Journal of Clinical Hematology 34(8): 919-927 (1993)

Phase II clinical study of recombinant human erythropoietin on the anemia of myelodysplastic syndrome
, Japanese Journal of Clinical Hematology 34(8): 928-936 (1993)

Phase II clinical study of topotecan hydrochloride in patients with recurrent advanced ovarian cancer
, Ai Zheng 21(4): 416-420 (2002)

Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 8(9): 2835-2842 (2002)

Phase II clinical trial of XYOTAX in non-small cell lung cancer to continue
, Expert Review of Anticancer Therapy 2(3): 244-245 (2002)

Phase II clinical trial of bolus infusion anti-B4 blocked ricin immunoconjugate in patients with relapsed B-cell non-Hodgkin's lymphoma
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(11): 2599-2604 (1998)

Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B
, Hepato-Gastroenterology 45(24): 2282-2294 (1998)

Phase II clinical trial of domestic amsacrine in patients with acute leukemias. Cooperative Group for Treating Acute Leukemias with Domestic m-AMSA
, Zhonghua Nei Ke Za Zhi 32(2): 80-84 (1993)

Phase II clinical trial of fludarabine in chronic lymphocytic leukemia on a weekly low-dose schedule
, Leukemia and Lymphoma 10(3): 187-193 (1993)

Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs
, Oncology Reports 10(1): 197-206 (2003)

Phase II clinical trial of nedaplatin in advanced non-small cell lung cancer
, Ai Zheng 21(12): 1354-1358 (2002)

Phase II clinical trial of preoperative combined chemoradiation for T3 and T4 resectable rectal cancer: preliminary results
, Diseases of the Colon and Rectum 44(8): 1113-1122 (2001)

Phase II clinical trial of sipatrigine (619C89) by continuous infusion in acute stroke
, Cerebrovascular Diseases 10(6): 431-436 (2000)

Phase II clinical trials in patients with lung cancer
, Nihon Kyobu Shikkan Gakkai Zasshi 31(Suppl): 232-244 (1993)

Phase II clinical trials of cisplatin-then-paclitaxel and paclitaxel-then-cisplatin in patients with previously untreated advanced epithelial ovarian cancer
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(12): 1603-1608 (2000)

Phase II collaborative pilot study: preliminary analysis of central neural effects from exposure to volatile anesthetics in the PACU
, Journal of Perianesthesia Nursing: Official Journal of the American Society of Perianesthesia Nurses 17(4): 240-250 (2002)

Phase II data on paclitaxel and docetaxel in gastrointestinal malignancies
, Recent Results in Cancer Research. Fortschritte der Krebsforschung. Progres Dans les Recherches sur le Cancer 142: 425-430 (1996)

Phase II dose escalation: a novel approach to balancing efficacy and toxicity of anticancer agents. Japanese Docetaxel Ovarian Cancer Study Group
, Anticancer Research 19(1b): 639-644 (1999)

Phase II dose-ranging trial of foscarnet salvage therapy for cytomegalovirus retinitis in AIDS patients intolerant of or resistant to ganciclovir (ACTG protocol 093). AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases
, Aids 8(4): 451-459 (1994)

Phase II double-blind, dose-ranging clinical evaluation of gadobenate dimeglumine in focal liver lesions: with analysis of liver and kidney signal change on early and delayed imaging
, Journal of Magnetic Resonance Imaging: Jmri 11(6): 655-664 (2000)

Phase II enzymes and bioactivation
, Canadian Journal of Physiology and Pharmacology 73(10): 1407-1413 (1995)

Phase II evaluation of a high-dose mitoxantrone based induction regimen in untreated adults with acute myeloid leukemia
, Leukemia and Lymphoma 38(3-4): 309-315 (2000)

Phase II evaluation of amifostine as an esophageal mucosal protectant in the treatment of limited-stage small cell lung cancer with chemotherapy and twice-daily radiation
, Seminars in Radiation Oncology 12(1 Suppl 1): 59-61 (2002)

Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest Oncology Group Study
, Cancer 88(5): 1159-1165 (2000)

Phase II evaluation of clinical coding schemes: completeness, taxonomy, mapping, definitions, and clarity. CPRI Work Group on Codes and Structures
, Journal of the American Medical Informatics Association: Jamia 4(3): 238-251 (1997)

Phase II evaluation of echinomycin (NSC-526417) in patients with central nervous system malignancies. A Southwest Oncology Group study
, Journal of Neuro-Oncology 15(2): 181-184 (1993 )

Phase II evaluation of low-dose oral etoposide for the treatment of relapsed or progressive AIDS-related Kaposi's sarcoma: an AIDS Clinical Trials Group clinical study
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(15): 3236-3241 (2002)

Phase II evaluation of suramin in advanced renal cell carcinoma. A Southwest Oncology Group study
, Urologic Oncology 6(4): 145-148 (2001)

Phase II evaluation of topotecan in patients with advanced colorectal cancer. A Southwest Oncology Group trial (SWOG 9241)
, Investigational new Drugs 15(4): 357-359 (1997)

Phase II multicenter clinical study of the platelet-activating factor receptor antagonist BB-882 in the treatment of sepsis
, Critical Care Medicine 28(3): 638-642 (2000)

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 15(4): 1567-1574 (1997)

Phase II multicenter trial of a weekly paclitaxel and carboplatin regimen in patients with advanced breast cancer
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(18): 3857-3864 (2002)

Phase II non-randomized study of three different sequences of docetaxel and vinorelbine in patients with advanced non-small cell lung cancer
, Lung Cancer 38(3): 309-315 (2002)

Phase II of bioethics: the turn to the social nature of individuals
, Bioethics Forum 11(3): 12-22 (1995)

Phase II of doxorubicin/taxol in metastatic breast cancer. Argentine Multicenter Taxol Group
, Breast Cancer Research and Treatment 55(1): 91-96 (1999)

Phase II of the AHCPR-sponsored heart failure guideline: translating practice recommendations into review criteria
, Joint Commission Journal on Quality Improvement 22(4): 265-276 (1996)

Phase II pilot study of combined chemohormonal therapy with doxorubicin and estramustine in metastatic prostate cancer
, American Journal of Clinical Oncology 23(6): 589-592 (2000)

Phase II protocol for the evaluation of new treatments in patients with advanced gastric carcinoma: results of ECOG 5282
, Medical Oncology 16(4): 261-266 (1999)

Phase II randomized multicenter study evaluating a treatment regimen alternating docetaxel and cisplatin-vinorelbine with a cisplatin-vinorelbine control group in patients with stage IV non-small-cell lung cancer: GFPC 97.01 study
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(5): 742-747 (2002)

Phase II randomized study of ISIS 3521 and ISIS 5132 in patients with locally advanced or metastatic colorectal cancer: a National Cancer Institute of Canada clinical trials group study
, Clinical cancer research: an official journal of the American Association for Cancer Research 8(7): 2188-2192 (2002)

Phase II randomized trial comparing high-dose cisplatin with moderate-dose cisplatin and carboplatin in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 12(2): 353-359 (1994)

Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(17): 3644-3650 (2002)

Phase II recovery rooms save space, money, staff
, Same-DaySurgery6(7):86 (1982)

Phase II results using a new antibody in the treatment of lymphoma
, Oncology 8(12): 84 87 (1994)

Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide)
, Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 34(8): 1260-1266 (1993)

Phase II single-agent studies in elderly cancer patients
, Tumori 88(1 Suppl 1): S13-S14 (2002)

Phase II studies of Elsamitrucin in breast cancer, colorectal cancer, non-small cell lung cancer and ovarian cancer. EORTC Early Clinical Trials Group
, Annals of Oncology: Official Journal of the European Society for Medical Oncology 5(4): 375-376 (1994)

Phase II studies of RMP-7 and carboplatin in the treatment of recurrent high grade glioma. RMP-7 European Study Group
, Journal of Neuro-Oncology 44(2): 137-145 (1999)

Phase II studies: which is worse, false positive or false negative?
, Journal of the National Cancer Institute 88(7): 462 (1996)

Phase II study of 13-cis-retinoic acid and interferon-alpha 2a in patients with advanced squamous cell lung cancer
, Anti-Cancer Drugs 4(1): 33-36 (1993)

Phase II study of 21 day schedule oral etoposide in children. New Agents Group of the United Kingdom Children's Cancer Study Group (UKCCSG)
, European Journal of Cancer 33(11): 1816-1822 (1997)

Phase II study of 3-hour infusion of high dose paclitaxel in refractory and relapsed aggressive non-Hodgkin's lymphomas. Groupe d'Etude des Lymphomes de l'Adulte
, Haematologica 85(5): 502-507 (2000)

Phase II study of 3-hour infusion of paclitaxel in patients with previously untreated stage III and IV non-small cell lung cancer. West Japan Lung Cancer Group
, Oncology 54(4): 298-303 (1997)

Phase II study of 3-hour infusion of paclitaxel in previously untreated non-small cell lung cancer
, Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2(6): 941-945 (1996)

Phase II study of 5-fluorouracil and leucovorin in recurrent primary brain tumor
, Journal of Neuro-Oncology 30(3): 243-246 (1996)

Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children
, Neuro-Oncology 2(1): 22-28 (2000)

Phase II study of CGS16949A, a new aromatase inhibitor--a dose finding study
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(4): 465-475 (1994)

Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group
, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 11(5): 909-913 (1993)

Phase II study of KRN8602 (MX2) for malignant lymphoma
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(7): 1001-1006 (1998)

Phase II study of NK 622 (toremifene citrate) in advanced breast cancer, a multicentral cooperative dose finding study
, Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(1): 79-90 (1993)

Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group
, Oncology 58(3): 191-197 (2000)

Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group
, British Journal of Cancer 83(2): 141-145 (2000)